10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2018

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

For the transition period from _________________ to _________________

Commission File Number: 000-33155

COATES INTERNATIONAL, LTD.

(Exact name of registrant as specified in its charter)

Nevada	22-2925432
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

2100 Highway 34, Wall Township, New Jersey 07719

(Address of principal executive offices) (Zip Code)

(732) 449-7717

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Non-accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)	Smaller reporting company ☒
	Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes ☐ No ☒

As of May 14, 2018, the Registrant had 59,338,954 shares of its common stock, par value $0.0001 per share issued and outstanding.

COATES INTERNATIONAL, LTD.

QUARTERLY REPORT ON FORM 10-Q

CONTENTS

MARCH 31, 2018

	Page
PART 1 – FINANCIAL INFORMATION
Item 1. Financial Statements:	1
Balance Sheets	1
Statements of Operations	2
Condensed Statements of Cash Flows	3
Notes to Financial Statements	4-22
Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations	23-30
Item 3.    Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.    Controls and Procedures	30
PART II  -  OTHER INFORMATION
Item 1.    Legal Proceedings	31
Item 1A. Risk Factors	31
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds	31
Item 3.    Defaults Upon Senior Securities	31
Item 4.    Mine Safety Disclosures	31
Item 5.    Other Information	32
Item 6.    Exhibits	32
SIGNATURES	33

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Coates International, Ltd.

Balance Sheets

	March 31, 2018			December 31, 2017
	(Unaudited)
Assets
Current Assets
Cash	$	48,496		$	6,807
Inventory		102,163			103,610
Other current assets		50,446			608
Total Current Assets		201,105			111,025
Property, plant and equipment, net		2,022,299			2,031,684
Deferred licensing costs, net		32,811			33,882
Total Assets	$	2,256,215		$	2,176,591
Liabilities and Stockholders' Deficiency
Current Liabilities
Accounts payable and accrued liabilities	$	2,660,903		$	2,544,003
Deferred compensation payable		1,708,332			1,621,322
Promissory notes to related parties		1,417,409			1,472,409
Mortgage loan payable		1,258,158			1,273,158
Derivative liability related to convertible promissory notes		496,704			358,996
Convertible promissory notes, net of unamortized discount		276,042			96,816
Unearned revenues		150,595			150,595
Sublicense deposits		19,200			60,725
Total Current Liabilities		7,987,343			7,578,024
Non-current portion of sublicense deposits		644,700			607,975
Total Liabilities		8,632,043			8,185,999
Commitments and Contingencies		-			-
Stockholders' Deficiency
Preferred stock, $0.001 par value, 350,000 shares authorized:
Series A Preferred Stock, 5,000 shares designated, 3,601 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively		4			4
Series B Convertible Preferred Stock, 345,000 shares designated, 281,378 and 228,471 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively		281			228
Common Stock, $0.0001 par value, 120,000 shares authorized, 45,300,694 and 36,943,242 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively		4,530			3,694
Additional paid-in capital		68,672,687			67,699,876
Accumulated deficit		(75,053,330	)		(73,713,210	)
Total Stockholders' Deficiency		(6,375,828	)		(6,009,408	)
Total Liabilities and Stockholders' Deficiency	$	2,256,215		$	2,176,591

The accompanying notes are an integral part of these financial statements.

1

Coates International, Ltd.

Statements of Operations

(Unaudited)

	For the Three Months Ended March 31,
	2018			2017
Sublicensing fee revenue	$	4,800		$	4,800
Total Revenues		4,800			4,800
Expenses:
Research and development costs		1,489			138,387
Stock-based compensation expense		589,384			191,325
Compensation and benefits		136,337			131,747
General and administrative expenses		122,704			118,839
Depreciation and amortization		11,007			12,249
Total Operating Expenses		860,931			592,547
Loss from Operations		(856,131	)		(587,747	)
Other Expenses:
Increase in estimated fair value of embedded derivative liabilities		(137,708	)		(51,277	)
Loss on conversion of convertible notes		(20,679	)		(11,629	)
Interest expense, net		(325,602	)		(196,515	)
Total other expenses		(483,989	)		(259,421	)
Loss Before Income Taxes		(1,340,120	)		(847,168	)
Provision for income taxes		-			-
Net Loss	$	(1,340,120	)	$	(847,168	)
Basic net loss per share	$	(0.03	)	$	(0.05	)
Basic weighted average shares outstanding		42,634,127			15,504,818
Diluted net loss per share	$	(0.03	)	$	(0.05	)
Diluted weighted average shares outstanding		42,634,127			15,504,818

The accompanying notes are an integral part of these financial statements.

2

Coates International, Ltd.

Statements of Cash Flows

(Unaudited)

	For the Three Months Ended March 31,
	2018			2017
Net Cash Used in Operating Activities	$	(138,825	)	$	(144,527	)
Net Cash Used in Investing Activities		-			-
Cash Flows Provided by Financing Activities:
Issuance of convertible promissory notes		265,200			90,000
Issuance of common stock under equity purchase agreements		-			42,944
Issuance of promissory note		-			25,000
Issuance of promissory notes to related parties		-			4,740
Repayment of promissory notes and accrued interest  to related parties		(65,434	)		(9,765	)
Repayment of mortgage loan		(15,000	)		(15,000	)
Net Cash Provided by Financing Activities		184,766			137,919
Net Increase (Decrease) in Cash		45,941			(6,608	)
Cash, beginning of period		2,555			9,163
Cash, end of period	$	48,496		$	2,555
Supplemental Disclosure of Cash Flow Information:
Cash paid during the year for interest	$	161,069		$	26,566
Supplemental Disclosure of Non-cash Financing Activities:
Conversion of convertible promissory notes	$	714,942		$	56,372

The accompanying notes are an integral part of these financial statements.

3

Coates International, Ltd.

Notes to Financial Statements

March 31, 2018

(All amounts rounded to thousands of dollars)

(Unaudited)

1. THE COMPANY AND BASIS OF PRESENTATION

Nature of Organization

Coates International, Ltd. (the “Company” or “CIL”) has acquired the exclusive licensing rights to the patented Coates spherical rotary valve (“CSRV^®”) system technology in North America, Central America and South America (the “CSRV^® License”). The CSRV^® system technology has been developed over a period of more than 20 years by the Company’s founder George J. Coates, President and Chief Executive Officer, and his son Gregory G. Coates. The CSRV^® system technology is adaptable for use in piston-driven internal combustion engines of many types and has been patented in the United States and numerous countries throughout the world. The Company is endeavoring to raise working capital to commence production of hydrogen gas and natural gas powered CSRV^® industrial electric power generator sets (“Gen Sets)” and is also seeking to enter into sublicense agreements with third party, original equipment manufacturers (“OEM’s”) which provide for licensing fees. The Company is also continuing with research and development of a hydrogen reactor to harvest Hydroxy-Gas from water with the intent to power the Company’s products, including large industrial Gen Sets. George J. Coates, owner of the hydrogen reactor technology, has committed to license this technology to the Company once the related patent protection is in place.

Management believes that the CSRV^® engines provide the following advantages as compared to conventional internal combustion engines designed with “poppet valves”:

● Improved fuel efficiency

● Lower levels of harmful emissions

● Adaptability to numerous types of engine fuels

● Longer engine life

● Longer intervals between engine servicing

The CSRV^® system technology is designed to replace the intake and exhaust conventional “poppet valves” currently used in almost all piston-driven, automotive, truck, motorcycle, marine and electric power generator engines, among others. Unlike conventional valves which protrude into the engine combustion chamber, the CSRV^® system technology utilizes spherical valves that rotate in a cavity formed between a two-piece cylinder head. The CSRV^® system technology utilizes significantly fewer moving parts than conventional poppet valve assemblies. As a result of these design improvements, management believes that engines incorporating the CSRV^® system technology (“CSRV^® Engines”) will last significantly longer and will require less lubrication over the life of the engine, as compared to conventional engines. In addition, CSRV^® Engines can be designed with larger openings into the engine cylinder than with conventional valves so that more fuel and air can be inducted into, and expelled from the cylinder in a shorter period of time. Larger valve openings permit higher revolutions-per-minute (RPM’s) and permit higher compression ratios with lower combustion chamber temperatures, allowing the Coates Engine^® to produce more power than equivalent conventional engines. The extent to which CSRV^® Engines operating with the CSRV^® system technology achieve (i) higher RPM’s, (ii) greater volumetric efficiency and (iii) thermal efficiency than conventional engines, is a function of the engine design and application.

4

Coates International, Ltd.

Notes to Financial Statements - (Continued)

Basis of Presentation

The accompanying condensed financial statements include the accounts of the Company. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed financial statements have been reclassified to conform to the current period’s presentation.

These condensed financial statements and accompanying notes should be read in conjunction with the Company’s annual financial statements and the notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2017 and the Company’s quarterly financial statements and the notes thereto included in its Quarterly Reports.

Since the Company’s inception, the Company has been responsible for the development costs of the CSRV^® technology in order to optimize the value of the licensing rights and has incurred related operational costs, the bulk of which have been funded primarily through cash generated from licensing fees, sales of stock, short term convertible promissory notes, capital contributions, loans made by George J. Coates, Bernadette Coates, his spouse, Gregory G. Coates and certain directors, fees received from research and development of prototype models and a small number of CSRV^® engine generator sales. The Company has incurred substantial cumulative losses from operations since its inception. Losses from operations are expected to continue until the CSRV^® Engines^® are successfully introduced into the marketplace enabling the Company to generate substantial sales and/or receive substantial licensing revenues. These losses from operations were primarily related to research and development of the Company’s intellectual property rights, patent filing and maintenance costs and general and administrative expenses. The Company has also reported substantial non-cash expenses for stock-based compensation, remeasurement of the estimated fair value of embedded derivative liabilities related to convertible promissory notes issued and interest expense and losses on conversion of convertible promissory notes.

As shown in the accompanying financial statements, the Company has incurred recurring losses from operations and, as of March 31, 2018, had a stockholders’ deficiency of ($6,376,000). In addition, our mortgage loan which had a principal balance of $1,258,000 at March 31, 2018, matures in July 2018. The Company will be required to renegotiate the terms of an extension of the mortgage loan or successfully refinance the property with another mortgage lender, if possible. Failure to do so could adversely affect the Company’s financial position and results of operations. In addition, the recent trading price range of the Company’s common stock has introduced additional difficulty to the Company’s challenge to secure needed additional working capital. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has instituted a cost control program intended to restrict variable costs to only those expenses that are necessary to complete its activities related to entering the production phase of operations, develop additional commercially feasible applications of the CSRV^® system technology, seek additional sources of working capital and cover general and administrative costs in support of such activities. The Company has been actively undertaking efforts to secure new sources of working capital. At March 31, 2018, the Company had negative working capital of ($7,786,000) compared with negative working capital of ($7,467,000) at the end of 2017.

The Company continues to actively seek out new sources of working capital; however, there can be no assurance that it will be successful in these efforts. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

5

Coates International, Ltd.

Notes to Financial Statements - (Continued)

Reverse Stock Split

The Company effected a one-for-200 reverse stock split of all of its outstanding shares of common stock, Series A Preferred Stock, Series B Convertible Preferred Stock, common stock warrants and stock options as of the close of trading on December 1, 2017. All prior year balances of shares of capital stock, warrants and stock options outstanding and all presentations and disclosures of transactions in shares of capital stock, warrants and stock options have been restated on a pro forma basis as if the reverse stock split had occurred prior to January 1, 2017. Such restatements include calculations regarding the Company’s weighted average shares outstanding and loss per share.

Inventory

Inventory consists of raw materials and work-in-process, including overhead. Inventory is stated at the lower of cost or net realizable value. Inventory is accounted for on the first-in, first-out method.

Use of Estimates

The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These significant estimates include determining the fair value of convertible promissory notes containing embedded derivatives and variable conversion rates, determining a value for shares of Series A Preferred Stock and Series B Convertible Preferred Stock issued, assigning useful lives to the Company’s property, plant and equipment, determining an appropriate amount to reserve for obsolete and slow moving inventory, estimating a valuation allowance for deferred tax assets, assigning expected lives to, and estimating the rate of forfeitures of, stock options granted and selecting a trading price volatility factor for the Company’s common stock in order to estimate the fair value of the Company’s stock options on the date of grant or other appropriate measurement date. Actual results could differ from those estimates.

2. CONCENTRATIONS OF CREDIT AND BUSINESS RISK

The Company maintains cash balances with one financial institution. Monies on deposit are fully insured by the Federal Deposit Insurance Corporation.

The Company’s operations are devoted to the development, application, licensing and marketing of the CSRV^® system technology which was invented by George J. Coates, the Company’s founder, Chairman, Chief Executive Officer, President and controlling stockholder. Development efforts have been conducted continuously during this time. From July 1982 through May 1993, seven U.S. patents as well as a number of foreign patents were issued with respect to the CSRV^® system technology. Since inception of the Company in 1988, all aspects of the business have been completely dependent upon the activities of George J. Coates. The loss of George J. Coates’ availability or service due to death, incapacity or otherwise would have a material adverse effect on the Company's business and operations. The Company does not presently have any key-man life insurance in force for Mr. Coates.

6

Coates International, Ltd.

Notes to Financial Statements - (Continued)

3. FAIR VALUE OF FINANCIAL INSTRUMENTS

Cash, Other Assets, Accounts Payable and Accrued Liabilities and Other Liabilities

With the exception of convertible promissory notes, the carrying amount of these items approximates their fair value because of the short term maturity of these instruments. The convertible promissory notes are reported at their estimated fair value, determined as described in more detail in Note 15.

Limitations

Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

4. LICENSING AGREEMENT AND DEFERRED LICENSING COSTS

The Company holds a manufacturing, use, lease and sale license from George J. Coates and Gregory G. Coates for the CSRV^® system technology in the territory defined as the Western Hemisphere (the “License Agreement”). Under the License Agreement, George J. Coates and Gregory G. Coates granted to the Company an exclusive, perpetual, royalty-free, fully paid-up license to the patented intellectual property that specifically relates to an internal combustion engine that incorporates the CSRV^® system technology (the “CSRV^® Engine”) and that is currently owned or controlled by them (the “CSRV^® Intellectual Property”), plus any CSRV^® Intellectual Property that is developed by them during their employment with the Company. In the event of insolvency or bankruptcy of the Company, the licensed rights would terminate and ownership would revert back to George J. Coates and Gregory G. Coates.

Under the License Agreement, George J. Coates and Gregory G. Coates agreed that they will not grant any Western Hemisphere licenses to any other party with respect to the CSRV^® Intellectual Property.

At March 31, 2018 and December 31, 2017, deferred licensing costs, comprised of expenditures for patent costs incurred pursuant to the CSRV^® licensing agreement, net of accumulated amortization, amounted to $33,000 and $34,000, respectively. Amortization expense for the three months ended March 31, 2018 and 2017 amounted to $1,000 and $1,000, respectively.

5. AGREEMENT ASSIGNED TO ALMONT ENERGY, INC.

In 2010, Almont Energy Inc. (“Almont”), a privately held, independent third-party entity based in Alberta, Canada became the assignee of a sublicense which covers the use of the CSRV^® system technology in the territory of Canada in the oil and gas industry (the “Canadian License”). This sublicense is currently inactive because the parties have not fulfilled their obligations thereunder due to the Company’s delay in starting up production and delivery of CSRV^® products to Almont. The parties mutually agreed to consider the basis on which the license could be reactivated at such time that the Company is successful in starting up its manufacturing operations.

7

Coates International, Ltd.

Notes to Financial Statements - (Continued)

In prior years, the Company received a non-refundable $300,000 deposit on the Canadian License. As the Company continues to be desirous of commencing shipments of its CSRV® products to Almont under the sublicense at such time that it is able to start up production operations, it has continued to amortize this deposit into income over the period until expiration of the last CSRV^® system technology patent in force. At March 31, 2018, amortization of the unamortized balance is as follows:

Year Ending	Amount
2018		14,000
2019		19,000
2020		19,000
2021		19,000
Thereafter		94,000
	$	165,000

At March 31, 2018 and December 31, 2017, the unamortized balance of this license deposit was $165,000 and $170,000, respectively. The current portion of $19,000 is included in sublicense deposits under current assets and the remainder of the balance is included in non-current sublicense deposits on the accompanying balance sheets at March 31, 2018 and December 31, 2017, respectively.

6. NON-EXCLUSIVE DISTRIBUTION SUBLICENSE WITH RENOWN POWER DEVELOPMENT, LTD.

In February 2015, the Company granted a non-exclusive distribution sublicense to Renown Power Development, Ltd., a China-based sales and distribution company (“Renown”) covering the territory defined as the Western Hemisphere. Under this sublicense, Renown will be permitted to sell, lease and distribute CSRV^® products. Renown intends to source CSRV^® products from Coates Power, Ltd., a China-based company formed for the purpose of manufacturing CSRV^® products (“Coates Power”). Coates Power has not been able to commence operations due to ongoing delays in obtaining necessary support and approval from the Chinese government in spite of continuing efforts by Renown to do so on its behalf. This has been and continues to be a long, arduous process because the government is addressing this at a very slow pace. As of March 31, 2018, the Company has only received an initial non-refundable deposit of $500,000. Until Coates Power can begin production of CSRV^® products for Renown, the Company will not receive any further monies from its sublicense with Renown.

At this time, as the Company’s intellectual property rights only cover the territory of North America, it does not have any rights to enter into a manufacturing and sale license agreement with Coates Power. These rights are currently held by George J. Coates, Gregory G. Coates and The Coates Trust, a trust controlled by George J. Coates. Coates Power and Renown are controlled and managed by Mr. James Pang, the Company’s liaison agent in China.

The Company received a $131,000 cash deposit with an order from Coates Power to produce two Gen Sets. This amount is included in Deposits in the accompanying balance sheets at March 31, 2018 and December 31, 2017. The Company intends to build and ship these two generators at such time that Coates Power is able to commence production in accordance with the manufacturing license agreement and there is sufficient working capital for this purpose.

7. OTHER CURRENT ASSETS

Other current assets at March 31, 2018 and December 31, 2017 amounted to $50,000 and $1,000, respectively. The balance at March 31, 2018 included $48,000 for inventory billed, but not received.

8. INVENTORY

Inventory consisted of the following:

	March 31, 2018		December 31, 2017
Raw materials	$	102,000	$	104,000

8

Coates International, Ltd.

Notes to Financial Statements - (Continued)

9. LICENSE DEPOSITS

Sublicensing fee revenue for the three months ended March 31, 2018 and 2017 amounted to $5,000 and $5,000, respectively.

10. PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment at cost, less accumulated depreciation, consists of the following:

	March 31, 2018			December 31, 2016
Land	$	1,235,000		$	1,235,000
Building		964,000			964,000
Building improvements		83,000			83,000
Machinery and equipment		689,000			689,000
Furniture and fixtures		57,000			57,000
		3,028,000			3.028,000
Less:  Accumulated depreciation		(1,006,000	)		(996,000	)
Total	$	2,022,000		$	2,032,000

Depreciation expense amounted to $10,000 and $11,000 for the three months ended March 31, 2018 and 2017, respectively.

11. MORTGAGE LOAN PAYABLE

The Company has a mortgage loan on the land and building that serves as its headquarters and research and development facility which bears interest at the rate of 7.5% per annum and matures in July 2018. Interest expense for the three months ended March 31, 2018 and 2017 amounted to $24,000 and $25,000, respectively. The loan requires monthly payments of interest, plus $5,000 which is being applied to the principal balance. The remaining principal balance at March 31, 2018 and December 31, 2017 was $1,258,000 and $1,273,000, respectively. The mortgage loan may be prepaid in whole, or, in part, at any time without penalty. The Company will be required to renegotiate the terms of a further extension of the mortgage loan or successfully refinance the property with another mortgage lender, if possible. Failure to do so, could adversely affect the Company’s financial position and results of operations.

The loan is collateralized by a security interest in all of the Company’s assets, the pledge of 25,000 shares of common stock of the Company owned by George J. Coates, which were deposited into escrow for the benefit of the lender and the personal guarantee of George J. Coates. The Company is not permitted to create or permit any secondary mortgage or similar liens on the property or improvements thereon without prior consent of the lender.

9

Coates International, Ltd.

Notes to Financial Statements - (Continued)

12. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities are as follows:

	March 31, 2018		December 31, 2017
Legal and professional fees	$	1,396,000	$	1,427,000
Accrued interest expense		622,000		582,000
General and administrative expenses		528,000		420,000
Research and development costs		115,000		115,000
Total	$	2,661,000	$	2,544,000

13. PROMISSORY NOTES TO RELATED PARTIES

Promissory Notes Issued to George J. Coates

During the three months ended March 31, 2018 and 2017, the Company issued, in a series of transactions, promissory notes to George J. Coates and received cash proceeds of $-0- and $4,000, respectively and repaid promissory notes to George J. Coates in the aggregate principal amount of $20,000 and $4,000, respectively. Interest expense for the three months ended March 31, 2018 and 2017 amounted to $13,000 and $13,000, respectively.

The promissory notes are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly. At March 31, 2018, the outstanding principal balance was $-0- and the balance of unpaid accrued interest was $331,000.

Promissory Note Issued to Gregory G. Coates

The Company has a non-interest bearing promissory note due to Gregory G. Coates which is payable on demand. Interest is being imputed on this promissory note at the rate of 10% per annum. During the three months ended March 31, 2018 and 2017, the Company, partially repaid $15,000 and $-0-, respectively of this promissory note. Imputed interest expense for the three months ended March 31, 2018 and 2017, amounted to $35,000 and $35,000, respectively. At March 31, 2018, the outstanding principal balance was $1,403,000.

Promissory Notes Issued to Bernadette Coates

During the three months ended March 31, 2018 and 2017, the Company issued promissory notes to Bernadette Coates, spouse of George J. Coates and received cash proceeds of $-0- and $1,000, respectively. The Company repaid promissory notes to Bernadette Coates in the principal amount of $15,000 and $6,000, respectively. The promissory notes are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly. Interest expense for the three months ended March 31, 2018 and 2017, amounted to $7,000 and $3,000, respectively. At March 31, 2018, the outstanding principal balance was $14,000.

Promissory Note Issued to Employee

The Company issued a promissory note to an employee which was payable on demand and provided for interest at the rate of 17% per annum, compounded monthly. In February 2018, this note was repaid in full along with accrued interest thereon of $1,400.

The aggregate amount of unpaid accrued interest on all promissory notes amounting to $432,000 is included in accounts payable and accrued liabilities in the accompanying balance sheet at March 31, 2018.

14. PROMISSORY NOTE

In March 2017, the Company issued a $25,000 promissory note with a maturity date of May 13, 2017. Interest was payable upon maturity in the form of 10,000,000 shares of unregistered, restricted shares of the Company's common stock. In addition, the Company agreed to extend warrants held by the lender to purchase 10,839,752 shares of common stock that were scheduled to expire in 2017 for an additional five years and modify the exercise price to $0.03 per share. On May 5, 2017, the Company prepaid the note in full and issued 8,688,525 shares of its common stock representing the prorated number of shares for interest on the note, as a result of the prepayment. Interest expense of $4,000 was recorded for issuance of these shares based on the closing trading price on the date of issuance.

10

Coates International, Ltd.

Notes to Financial Statements - (Continued)

15. CONVERTIBLE PROMISSORY NOTES AND EMBEDDED DERIVATIVE LIABILITY

From time to time, the Company issues convertible promissory notes, the proceeds of which are used for general working capital purposes. At March 31, 2018, there was $385,000 principal amount of convertible promissory notes outstanding. During the three months ended March 31, 2018 and 2017, $287,000 and $93,000 of convertible promissory notes were issued, respectively. Outstanding notes may be converted into unregistered shares of the Company’s common stock at a discount ranging from 30% to 39% of the defined trading price of the common stock on the date of conversion. The defined trading prices are based on the trading price of the stock during a defined period ranging from ten to twenty-five trading days immediately preceding the date of conversion. The conversion rate discount establishes a beneficial conversion feature (“BCF”) or unamortized discount, which is required to be valued and accreted to interest expense over the six-month period until the conversion of the notes into restricted shares of common stock is permitted. In addition, the conversion formula meets the conditions that require accounting for convertible notes as derivative liability instruments. The effective interest rate on the outstanding convertible notes at March 31, 2018 ranged from 107% to 147%. The unamortized discount on the outstanding convertible notes at March 31, 2018 and December 31, 2017 amounted to $116,000 and $52,000, respectively.

The convertible notes generally become convertible, in whole, or in part, beginning on the six month anniversary of the issuance date and may be prepaid at the option of the Company, with a prepayment penalty ranging from 15% to 50% of the principal amount of the convertible note at any time prior to becoming eligible for conversion.

One convertible promissory note with an aggregate outstanding balance of $53,000 is convertible in monthly installments in an amount determined by the noteholder, plus accrued interest. The Company may elect, at its option to repay each monthly installment in whole, or in part, in cash, without penalty. The amount of each installment not paid in cash is converted into shares of the Company’s common stock. This convertible note also requires that the conversion price be re-measured 23 trading days after the conversion shares are originally delivered. If the re-measured conversion price is lower, then the Company is required to issue additional conversion shares to the noteholder.

In accordance with GAAP, the estimated fair value of the embedded derivative liability related to the convertible notes is required to be remeasured at each balance sheet date. The fair value measurement accounting standard establishes a valuation hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used, when available. Observable inputs are inputs market participants would use in valuing the asset or liability developed based on independent market data sources. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available. The valuation hierarchy is composed of three categories, which are as follows:

● Level 1 – Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.

● Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly.

● Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques.

11

Coates International, Ltd.

Notes to Financial Statements - (Continued)

The estimated fair value of the embedded derivative liabilities related to promissory notes outstanding was measured as the aggregate estimated fair value, based on Level 2 inputs, which included quoted daily yield curve rates of treasury securities with comparable maturities and, because the actual volatility rate on the Company’s common stock is not available, a conservative estimated volatility rate of 200%.

The embedded derivative liability arises because, based on historical trading patterns of the Company’s stock, the formula for determining the Conversion Rate is expected to result in a different Conversion Rate than the closing price of the stock on the actual date of conversion (hereinafter referred to as the “Variable Conversion Rate Differential”). The estimated fair values of the derivative liabilities have been calculated based on a Black-Scholes option pricing model.

The following table presents the Company's fair value hierarchy of financial assets and liabilities measured at fair value at:

	March 31, 2018		December 31, 2017
Level 1 Inputs	$	-	$	-
Level 2 Inputs		497,000		359,000
Level 3 Inputs		-		-
Total	$	497,000	$	359,000

In a series of transactions, during the three months ended March 31, 2018, convertible promissory notes with an aggregate principal balance of $82,000, including accrued interest thereon were converted into 8,357,452 unregistered shares of common stock. The Company incurred a loss on these conversions amounting to $21,000 for the three months ended March 31, 2018.

In a series of transactions, during the three months ended March 31, 2017, convertible promissory notes with an aggregate principal balance of $56,000, including accrued interest thereon were converted into 854,365 unregistered shares of common stock. The Company incurred a loss on these conversions amounting to $12,000 for the three months ended March 31, 2017.

At March 31, 2018, the Company did not have enough unissued, authorized shares of its common stock to meet the 160,748,286-share aggregate contractual reserve requirements of its outstanding convertible debt. This was due to the filing of a Certificate of Validation with the Secretary of State of Delaware on April 2, 2018, as more fully discussed in Note 24, which reduced the number of authorized shares of common stock from 12,000,000,000 to 120,000,000. This reduction was retroactive to the close of trading in the Company's common stock on December 1, 2017. The Company has obtained 90-day waivers of this default from each of the convertible noteholders. As discussed in more detail in Note 24, on May 7, 2018, the Company filed a Notice of Conversion with the Secretary of State of Nevada, which increased the number of authorized shares of the Company's common stock from 120,000,000 to 2,400,000,000, thereby automatically curing this default condition for all convertible notes. At March 31, 2018, $149,000 of the Company’s outstanding convertible notes were eligible for conversion.

The Company made the private placement of these securities in reliance upon Section 4(2) of the Securities Act of 1933, as amended (the “Act”), Rule 506 of Regulation D, and the rules and regulations promulgated thereunder, and/or upon any other exemption from the registration requirements of the Act, as applicable.

16. CAPITAL STOCK

Common Stock

The Company’s common stock is traded on OTC Pink Sheets. Investors can find real-time quotes and market information for the Company at www.otcmarkets.com market system under the ticker symbol COTE. The Company is authorized to issue up to 120,000,000 shares of common stock, par value, $0.0001 per share (the “Common Stock”). 

At the close of trading in the Company’s common stock on December 1, 2017, a 1:200 reverse stock split of all of the Company’s shares of common stock, shares of preferred stock, common stock warrants and stock options became effective. Shareholders were paid cash-in-lieu of any fractional shares that would have resulted in connection with the reverse stock split. The reverse stock split was approved by the board of directors and George J. Coates, the majority stockholder by means of a written consent. For purposes of presenting the accompanying financial statements as of March 31, 2018 and December 31, 2017 and for the three months ended March 31, 2018, all balances, transactions and calculations were restated on a pro forma basis as if the reverse stock split occurred prior to the beginning of the year ended December 31, 2017.

12

Coates International, Ltd.

Notes to Financial Statements - (Continued)

The following common stock transactions occurred during the three months ended March 31, 2018: 

● In a series of transactions, convertible promissory notes with an aggregate principal balance of $82,000, including accrued interest thereon were converted into 8,375,452 unregistered shares of common stock.

The following common stock transactions occurred during the nine months ended September 30, 2017: 

● In a series of transactions during the three months ended March 31, 2017, convertible promissory notes with an aggregate principal balance of $56,000, including accrued interest thereon were converted into 854,365 unregistered shares of common stock.

● During the three months ended March 31, 2017, Barry C. Kaye converted 6.86 shares of Series B into 6,860 unregistered, restricted shares of the Company’s common stock.

Preferred Stock and anti-dilution rights

The Company is authorized to issue 350,000 shares of preferred stock, par value, $0.001 per share (the “Preferred Stock”). The Company may issue any class of the Preferred Stock in any series. The board is authorized to establish and designate series, and to fix the number of shares included in each such series and the relative rights, preferences and limitations as between series, provided that, if the stated dividends and amounts payable on liquidation are not paid in full, the shares of all series of the same class shall share ratably in the payment of dividends including accumulations, if any, in accordance with the sums which would be payable on such shares if all dividends were declared and paid in full and in any distribution of assets other than by way of dividends in accordance with the sums which would be payable on such distribution if all sums payable were discharged in full. Shares of each such series when issued, shall be designated to distinguish the shares of each series from shares of all other series. 

There are two series of Preferred Stock that have been designated to date from the total 100,000,000 authorized shares of Preferred Stock. These are as follows: 

● Series A Preferred Stock, par value $0.001 per share (“Series A”), 5,000 shares designated, 3,601 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively. Shares of Series A entitle the holder to 10,000 votes per share on all matters brought before the shareholders for a vote. These shares are not entitled to receive dividends or share in distributions of capital and have no liquidation preference. All outstanding shares of Series A are owned by George J. Coates, which entitle him to 36,010,000 million votes in addition to his voting rights from the shares of common stock and the shares of Series B he holds.

The Company may issue additional shares of Series A Preferred Stock to Mr. Coates if deemed necessary to provide anti-dilution protection and maintain his ownership percentage of eligible votes.

Issuances of shares of Series A to George J. Coates do not have any effect on the share of dividends or liquidation value of the holders of the Company’s common stock. However, the voting rights of the holders of the Company’s common stock are diluted with each issuance.

During the three months ended March 31, 2017, the Company issued 3,351 shares of Series A Preferred Stock to George J. Coates representing anti-dilution shares to restore Mr. Coates’ percentage of eligible votes to 85.7%. This percentage increased as a result of Mr. Coates’ acquisition of additional shares of common stock in 2016.

13

Coates International, Ltd.

Notes to Financial Statements - (Continued)

● Series B Convertible Preferred Stock, par value $0.001 per share, 345,000 shares designated and 281,378 and 228,471 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively. Shares of Series B do not earn any dividends and may be converted at the option of the holder at any time beginning on the second annual anniversary date after the date of issuance into 1,000 unregistered shares of the Company’s common stock. Holders of the Series B are entitled to one thousand votes per share held on all matters brought before the shareholders for a vote.

In the event that either (i) the Company enters into an underwriting agreement for a secondary public offering of securities, or (ii) a change in control of the Company is consummated representing 50% more of the then outstanding shares of Company’s common stock, plus the number of shares of common stock into which any convertible preferred stock is convertible, regardless of whether or not such shares are otherwise eligible for conversion, then the Series B may be immediately converted at the option of the holder into restricted shares of the Company’s common stock. 

The Company provides anti-dilution protection for certain of its key employees. For each new share of common stock issued by the Company to non-Coates family members in the future, additional shares of Series B will be issued to maintain their fixed ownership percentage of the Company. The fixed ownership percentage is adjusted for acquisitions and dispositions of common stock, not related to conversions of Series B Convertible Preferred Stock, by these key employees. At March 31, 2018, the fixed ownership percentages were as follows:

1. George J. Coates – 80.63%

2. Gregory G. Coates – 6.10%

3. Barry C. Kaye – 0.048%

These anti-dilution provisions do not apply to new shares of common stock issued in connection with exercises of employee stock options, a secondary public offering of the Company’s securities or a merger or acquisition.

The following presents by year, the number of shares of Series B held and the year that they become eligible for conversion into shares of common stock, as of March 31, 2018.

	Total		2018		2019		2020
George J. Coates		260,020		74,506		136,599		48,915
Gregory G. Coates		19,832		5,484		10,646		3,702
Barry C. Kaye		1,526		413		823		290
Total		281,378		80,403		148,068		52,907

For the three months ended March 31, 2018, 48,915, 3,702 and 290 shares of Series B were issued to George J. Coates, Gregory G. Coates and Barry C. Kaye, respectively, having an estimated fair value of $545,000, $41,000 and $3,000, respectively. These amounts were included in stock-based compensation expense in the accompanying statement of operations for the three months ended March 31, 2018.

For the three months ended March 31, 2017, 3,861, 597 and 47 shares of Series B were issued to George J. Coates, Gregory G. Coates and Barry C. Kaye, respectively, having an estimated fair value of $132,000, $39,000 and $3,000, respectively. These amounts were included in stock-based compensation expense in the accompanying statement of operations for the nine months ended March 31, 2017.

14

Coates International, Ltd.

Notes to Financial Statements - (Continued)

During the three months ended March 31, 2017, Barry C. Kaye converted 6.86 shares of Series B into 6,868 unregistered, restricted shares of the Company’s common stock.

In the event that all of the 281,378 shares of Series B outstanding at March 31, 2018 were converted, once the conversion restrictions lapse, an additional 281,378,000 new restricted shares of common stock would be issued. On a pro forma basis, based on the number of shares of common stock outstanding at March 31, 2018, this would dilute the ownership percentage of non-affiliated stockholders from 85.4% to 12.8%.

To the extent that additional shares of Series B are issued under the anti-dilution plan, the non-affiliated stockholders’ percentage ownership of the Company would be further diluted.

17. LOSS PER SHARE

At March 31, 2018, there were stock warrants outstanding to purchase 741,725 shares of common stock at exercise prices ranging from $0.10 to $13.50 per share, vested stock options outstanding to acquire 62,350 shares of common stock at exercise prices ranging from $5.60 to $88.00 per share and $385,000 of convertible promissory notes outstanding, which on a pro forma basis assuming all such promissory notes were converted into shares of common stock using the contractual conversion price determined as of the close of trading on the last trading in March 2018, would have been convertible into 33,314,645 shares of common stock.

At March 31, 2017, there were stock warrants outstanding to purchase 751,725 shares of common stock at exercise prices ranging from $0.10 to $13.50 per share, vested stock options outstanding to acquire 62,350 shares of common stock at exercise prices ranging from $5.60 to $88.00 per share and $140,000 of convertible promissory notes outstanding, which on a pro forma basis assuming all such promissory notes were converted into shares of common stock using the contractual conversion price determined as of the close of trading on the last trading in March 2017, would have been convertible into 3,257,093 shares of common stock.

For the three months ended March 31, 2018 and 2017, none of the potentially issuable shares of common stock were assumed to be converted because the Company incurred a net loss in those periods and the effect of including them in the calculation of earnings per share would have been anti-dilutive.

18. STOCK OPTIONS

The Company’s 2006 Stock Option and Incentive Plan (the “Stock Plan”) was adopted by the Company’s board in October 2006. In September 2007, the Stock Plan, by consent of George J. Coates, majority shareholder, was adopted by our shareholders. The Stock Plan provides for the grant of stock-based awards to employees, officers and directors of, and consultants or advisors to, the Company and its subsidiaries, if any. Under the Stock Plan, the Company may grant options that are intended to qualify as incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (“ISO’s”), options not intended to qualify as incentive stock options (“non-statutory options”), restricted stock and other stock-based awards. ISO’s may be granted only to employees of the Company. All of the shares of common stock authorized under the Stock Plan have been granted and no further grants may be awarded thereunder.

The Company established a 2014 Stock Option and Incentive Plan (the “2014 Stock Plan”) which was adopted by the Company’s board on May 30, 2014. On March 2, 2015, the 2014 Stock Plan, by consent of George J. Coates, majority shareholder, was adopted by our shareholders. The 2014 Stock Plan provides for the grant of stock-based awards to employees, officers and directors of, and consultants or advisors to, the Company and its subsidiaries, if any. Under the 2014 Stock Plan, the Company may grant ISO’s, non-statutory options, restricted stock and other stock-based awards. ISO’s may be granted only to employees of the Company. A total of 50,000,000 shares of common stock may be issued upon the exercise of options or other awards granted under the 2014 Stock Plan. The maximum number of shares with respect to which awards may be granted during any one year to any employee under the 2014 Stock Plan shall not exceed 25% of the 50,000,000 shares of common stock covered by the 2014 Stock Plan. At June 30, 2017, none of the shares of common stock authorized under the 2014 Stock Plan had been granted as stock options or awards.

15

Coates International, Ltd.

Notes to Financial Statements - (Continued)

The Stock Plan and the 2014 Stock Plan (the “Stock Plans”) are administered by the board and the Compensation Committee. Subject to the provisions of the Stock Plans, the board and the Compensation Committee each has the authority to select the persons to whom awards are granted and determine the terms of each award, including the number of shares of common stock subject to the award. Payment of the exercise price of an award may be made in cash, in a “cashless exercise” through a broker, or if the applicable stock option agreement permits, shares of common stock, or by any other method approved by the board or Compensation Committee. Unless otherwise permitted by the Company, awards are not assignable or transferable except by will or the laws of descent and distribution.

Upon the consummation of an acquisition of the business of the Company, by merger or otherwise, the board shall, as to outstanding awards (on the same basis or on different bases as the board shall specify), make appropriate provision for the continuation of such awards by the Company or the assumption of such awards by the surviving or acquiring entity and by substituting on an equitable basis for the shares then subject to such awards either (a) the consideration payable with respect to the outstanding shares of common stock in connection with the acquisition, (b) shares of stock of the surviving or acquiring corporation, or (c) such other securities or other consideration as the board deems appropriate, the fair market value of which (as determined by the board in its sole discretion) shall not materially differ from the fair market value of the shares of common stock subject to such awards immediately preceding the acquisition. In addition to, or in lieu of the foregoing, with respect to outstanding stock options, the board may, on the same basis or on different bases as the board shall specify, upon written notice to the affected optionees, provide that one or more options then outstanding must be exercised, in whole or in part, within a specified number of days of the date of such notice, at the end of which period such options shall terminate, or provide that one or more options then outstanding, in whole or in part, shall be terminated in exchange for a cash payment equal to the excess of the fair market value (as determined by the board in its sole discretion) for the shares subject to such stock options over the exercise price thereof. Unless otherwise determined by the board (on the same basis or on different bases as the board shall specify), any repurchase rights or other rights of the Company that relate to a stock option or other award shall continue to apply to consideration, including cash, that has been substituted, assumed or amended for a stock option or other award pursuant to these provisions. The Company may hold in escrow all or any portion of any such consideration in order to effectuate any continuing restrictions.

The board may at any time provide that any stock options shall become immediately exercisable in full or in part, that any restricted stock awards shall be free of some or all restrictions, or that any other stock-based awards may become exercisable in full or in part or free of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be.

The board or Compensation Committee may, in its sole discretion, amend, modify or terminate any award granted or made under the Stock Plan, so long as such amendment, modification or termination would not materially and adversely affect the participant.

During the three months ended March 31, 2018 and 2017, no stock options were granted. There were no unvested stock options outstanding at March 31, 2018.

During the three months ended March 31, 2018 and 2017, the Company did not incur any stock-based compensation expense related to employee stock options. At March 31, 2018, all stock-based compensation expense related to outstanding stock options had been fully recognized.

16

Coates International, Ltd.

Notes to Financial Statements - (Continued)

Details of the stock options outstanding under the Company’s Stock Option Plans are as follows:

	Exercise Price Per Share		Number Outstanding		Weighted Average Remaining Contractual Life		Number Exercisable		Weighted Average Exercise Price		Weighted Average Fair Value Per Stock Option at Date of Grant
Balance, 3/31/18	$	5.60 – $88.00		62,500		9		62,500	$	36.34	$	33.84

No stock options were exercised, forfeited or expired during the three months ended March 31, 2018 and 2017.

The weighted average fair value of the Company's stock options was estimated using the Black-Scholes option pricing model which requires highly subjective assumptions including the expected stock price volatility. These assumptions were as follows:

●	Historical stock price volatility	139% - 325%
●	Risk-free interest rate	0.21% - 4.64%
●	Expected life (in years)	4
●	Dividend yield	$0.00

The valuation assumptions were determined as follows:

● Historical stock price volatility: The Company utilized the volatility in the trading of its common stock computed for the 12 months of trading immediately preceding the date of grant.

● Risk-free interest rate: The Company bases the risk-free interest rate on the interest rate payable on U.S. Treasury securities in effect at the time of the grant for a period that is commensurate with the assumed expected option life.

● Expected life: The expected life of the options represents the period of time options are expected to be outstanding. The Company has very limited historical data on which to base this estimate. Accordingly, the Company estimated the expected life based on its assumption that the executives will be subject to frequent blackout periods during the time that the stock options will be exercisable and based on the Company’s expectation that it will complete its research and development phase and commence its initial production phase. The vesting period of these options was also considered in the determination of the expected life of each stock option grant.

● No expected dividends.

19. INCOME TAXES

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

Deferred tax assets increased by $247,000 and $833,000 for the three months ended March 31, 2018 and 2017, respectively. These amounts were fully offset by a corresponding increase in the tax valuation allowance resulting in no net change in deferred tax assets, respectively, during these periods.

No liability for unrecognized tax benefits was required to be reported at March 31, 2018 and December 31, 2017.  Based on the Company's evaluation, it has concluded that there are no significant uncertain tax positions requiring recognition in the Company's financial statements. The Company's evaluation was performed for tax years ended 2014 through 2016, the only periods subject to examination. The Company believes that its income tax positions and deductions will be sustained on audit and does not anticipate that adjustments, if any, will result in a material change to its financial position. For the three months ended March 31, 2018 and 2017, there were no penalties or interest related to the Company’s income tax returns.

17

Coates International, Ltd.

Notes to Financial Statements - (Continued)

At March 31, 2018, the Company had available, $20,908,000 of net operating loss carryforwards which may be used to reduce future federal taxable income, expiring between 2018 and 2038 and $10,504,000 of net operating loss carryforwards which may be used to reduce future state taxable income, expiring between 2029 and 2038.

20. RELATED PARTY TRANSACTIONS

Licensing Agreement for CSRV^® System Technology

The Company’s intellectual property rights for the CSRV^® System Technology are derived from the licensing agreement with George J. Coates and Gregory G. Coates, as more fully discussed in Note 4. The Company pays for all costs of new patent filings and patent maintenance on intellectual properties licensed to it by George J. Coates and Gregory G. Coates. For the three months ended March 31, 2018 and 2017, these costs amounted to $4,000 and $4,000, respectively.

Non-Exclusive distribution sublicense to Renown Power Development, Ltd.

The Company has granted a non-exclusive distribution sublicense to Renown, as more fully discussed in Note 6. Renown is controlled by James Pang, the Company’s exclusive liaison agent in China.

Issuances of Promissory Notes to Related Parties

Issuances of promissory notes to related parties during the three months ended March 31, 2018 and 2017, are discussed in detail in Note 15.

Promissory notes issued to George J. Coates, Bernadette Coates and an employee are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly. The promissory note issued to Gregory G. Coates is non-interest bearing, however, the Company imputes interest at a rate of 10% per annum, which has been charged to interest expense in the accompanying statements of operations.

Stock Options

Stock options previously granted to related parties, all of which are fully vested are more fully discussed in Note 18.

Issuances and Conversions of Preferred Stock

Shares of Series A Preferred Stock awarded to George J. Coates during the three months ended March 31, 2018 and 2017 are discussed in detail in Note 16.

Shares of Series B Convertible Preferred Stock awarded to George J. Coates, Gregory G. Coates and Barry C. Kaye and shares converted during the three months ended March 31, 2018 and 2017, are discussed in detail in Note 16.

Personal Guaranty and Stock Pledge

In connection with the Company’s mortgage loan on the Company’s headquarters facility, George J. Coates has pledged certain of his shares of common stock of the Company to the extent required by the lender and provided a personal guaranty as additional collateral.

18

Coates International, Ltd.

Notes to Financial Statements - (Continued)

Compensation and Benefits Paid

The approximate amount of compensation and benefits, all of which were approved by the board, paid to George J. Coates, Gregory G. Coates and Bernadette Coates, exclusive of stock-based compensation for unregistered, restricted shares of Preferred Stock awarded to George J. Coates and Gregory G. Coates is summarized as follows:

	For the three months ended March 31,
	2018		2017
George J. Coates (a) (b)	$	4,000	$	14,000
Gregory G. Coates (c) (d)		24,000		3,000
Bernadette Coates (e)		-		-

(a) For the three months ended March 31, 2018 and 2017, George J. Coates earned additional base compensation of $63,000 and $53,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $1,283,000 and $1,221,000, respectively.

(b) During the three months ended March 31, 2018 and 2017, George J. Coates was awarded Series A Preferred Stock and Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

(c) For the three months ended March 31, 2018 and 2017, Gregory G. Coates earned additional base compensation of $19,000 and $38,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $161,000 and $143,000, respectively.

(d) During the three months ended March 31, 2018 and 2017, Gregory G. Coates was awarded Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

(e) The Company had been deferring base compensation for Bernadette Coates, who retired in 2016, until it has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $242,000.

During the three months ended March 31, 2018 and 2017, Barry C. Kaye, Treasurer and Chief Financial Officer was paid compensation of $35,000 and $10,000, respectively. For the three months ended March 31, 2018 and 2017, Mr. Kaye earned compensation of $33,000 and $32,000, respectively, which was not paid and is being deferred until the Company has sufficient working capital to remit payment to him. During the three months ended March 31, 2018 and 2017, interest accrued on Mr. Kaye’s deferred compensation amounted to $18,000 and $13,000, respectively. At March 31, 2018, the total amount of Mr. Kaye’s unpaid, deferred compensation, including accrued interest thereon, was $434,000. This amount is included in accounts payable and accrued liabilities in the accompanying balance sheet at March 31, 2018. During the three months ended March 31, 2018 and 2017, Barry C. Kaye was awarded Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

At March 31, 2018 the Company owed deferred compensation to an employee in the amount of $22,000, payment of which is being deferred until the Company has sufficient working capital. This amount is included in deferred compensation in the accompanying balance sheet at March 31, 2018.

19

Coates International, Ltd.

Notes to Financial Statements - (Continued)

21. CONTRACTUAL OBLIGATIONS AND COMMITMENTS

The following table summarizes the Company’s contractual obligations and commitments at March 31, 2018:

	Total		2018		2019
Deferred compensation	$	1,708,000	$	1,708,000	$	-
Promissory notes to related parties		1,418,000		1,418,000		-
Mortgage loan payable		1,258,000		1,258,000		-
Convertible promissory notes		392,000		340,000		52,000
Total	$	4,776,000	$	4,724,000	$	52,000

22. LITIGATION AND CONTINGENCIES

The Company is not a party to any litigation that is material to its business.

23. RECENTLY ISSUED ACCOUNTING STANDARDS

Revenue Recognition

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled to when products are transferred to customers. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606) – Deferral of the Effective Date, which defers the effective date of ASU 2014-09 for one year and permits early adoption. The Company intends to adopt this standard in its first quarter of 2019.

In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606) – Identifying Performance Obligations and Licensing (“ASU 2016-10”), which amends the guidance in ASU 2014-09 related to identifying performance obligations and accounting for licenses of intellectual property. The Company will adopt ASU 2016-10 with ASU 2014-09. The Company is currently evaluating the impact of adopting the new revenue recognition standard, as amended, but does not expect it to have a material impact on its financial statements.

Stock Compensation

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. The Company is currently evaluating the impact of adopting the new stock compensation standard, but does not expect it to have a material impact on its financial statements.

Financial Instruments

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10) (“ASU 2016-01”), which updates certain aspects of recognition, measurement, presentation and disclosure of financial instruments. ASU 2016-01 will be effective for the Company beginning in its first quarter of 2019. The Company does not believe the adoption of the new financial instruments standard will have a material impact on its financial statements.

20

Coates International, Ltd.

Notes to Financial Statements - (Continued)

24. SUBSEQUENT EVENTS

Certificate of Validation

On April 2, 2018, the Company filed a certificate of validation with the state of Delaware which had retroactive effect to the close of trading in the Corporation’s common stock on December 1, 2017, in order to:

(i)	cure certain technical, procedural defects related to the 1:200 reverse stock split, which became effective at the close of trading on December 31, 2017,
(ii)	clarify that the reverse stock split effected a 1:200 reduction in the number of the Corporation’s authorized shares of common stock, from 12,000,000,000 to 60,000,000, with retroactive effect to the close of trading on December 1, 2017,
(iii)	clarify that the reverse stock split effected 1:200 reduction in the number of authorized shares of the Corporation’s preferred stock, from 100,000,000 to 500,000 with retroactive effect to the close of trading on December 1, 2017; and,
(iv)	concurrently therewith, further amend the Corporation’s Amended Certificate of Articles of Incorporation with the State of Delaware to increase the number of the Corporation’s authorized shares of common stock, par value $0.0001 from 60,000,000 to 120,000,000 and reduce the number of authorized shares of the Corporation’s preferred stock, par value $0.001 from 500,000 to 350,000.

The above corporate action was authorized by the board of directors on February 28, 2018, and by means of obtaining the written consent of George J. Coates, the sole majority stockholder, was approved by the shareholders on March 1, 2018.

Certificate of Conversion and Certificate of Designation

On May 9, 2018, the Company filed a Certificate of Conversion and a Certificate of Designation which caused the following corporate actions to become effective:

(i)	The Corporation’s State of Domicile was converted from the State of Delaware to the State of Nevada.
(ii)	The number of authorized shares of capital stock of the Company was increased to:

a. 2,400,000,000 shares of common stock, par value $0.0001 per share

b. 100,000,000 shares of preferred stock, par value $0.001 per share

(iii) The series and number of shares of preferred stock designated from the 100,000,000 shares of preferred stock authorized, was increased to:

a. 1,000,000 shares of Series A Preferred Stock, $0.001 per share

b. 10,000,000 shares of Series B Convertible Preferred Stock, $0.001 per share

Section 3(a)10 Exempt Securities Transaction

On March 19, 2018, the Company entered into a Settlement Agreement and Stipulation (the “Settlement Agreement”) with Livingston Asset Management LLC, a Florida limited liability company (“LAM”), pursuant to which the Company agreed to issue common stock to LAM in exchange for the settlement of $69,000 (the “Settlement Amount”) of past-due obligations and accounts payable of the Company. LAM purchased the obligations and accounts payable from certain vendors of the Company as described below.

21

Coates International, Ltd.

Notes to Financial Statements - (Continued)

On April 2, 2018, the Circuit Court of Baltimore County, Maryland (the “Court”), entered an order (the “LAM Order”) approving, among other things, the fairness of the terms and conditions of an exchange in reliance upon an exemption from registration provided for in Section 3(a)(10) of the Securities Act of 1933, as amended (the “Securities Act”), in accordance with a stipulation of settlement, pursuant to the Settlement Agreement between the Company and LAM. Pursuant to the court order, LAM commenced an action against the Company to recover an aggregate of $69,000 of past-due obligations and accounts payable of the Company, which LAM had purchased from certain vendors of the Company pursuant to the terms of separate claim purchase agreements between LAM and each of such vendors (the “LAM Assigned Accounts”). The LAM Assigned Accounts relate to certain accounting services provided to the Company and a supplier invoice. The Settlement Agreement became effective and binding upon the Company and LAM upon execution of the Order by the Court on April 2, 2018.

Pursuant to the terms of the Settlement Agreement approved by the LAM Order, on April 2, 2018, the Registrant agreed to issue shares to LAM (the “LAM Settlement Shares”) of the Registrant’s common stock at a 30% discount from the selling price of the settlement shares sold by LAM, as defined in the settlement agreement. The Settlement Agreement provides that the LAM Settlement Shares will be issued in one or more tranches, as necessary, sufficient to satisfy the settlement amount through the issuance of freely trading securities issued in reliance upon an exemption provided for in Section 3(a)(10) of the Securities Act. The parties reasonably estimate that the fair market value of the LAM Settlement Shares to be received by LAM is equal to approximately $99,000. Additional tranche requests shall be made as requested by LAM until the LAM Settlement Amount is paid in full.

The Settlement Agreement provides that in no event shall the number of shares of Common Stock issued to LAM or its designee in connection with the Settlement Agreement, when aggregated with all other shares of Common Stock then beneficially owned by LAM and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder), result in the beneficial ownership by LAM and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and the rules and regulations thereunder) at any time of more than 9.99% of the Common Stock.

The Company is required to reserve a sufficient number of shares of its Common Stock to provide for issuances thereof, upon full satisfaction of the Settlement Amount.

During the period from April 6, 2018 through May 14, 2018, the Company issued 8,970,000 shares of Common Stock to LAM to be sold in the open market in reliance upon an exemption provided for in Section 3(a)(10) of the Securities Act. Proceeds from the sales are to be used to satisfy past-due obligations of the Company previously assigned to LAM. During the period from April 6, 2018 through May 14, 2018, Lam has paid $40,000 of the Settlement Amount of the Company's past due obligations in accordance with the Settlement Agreement.

Conversion of Convertible Promissory Notes

During the period from April 1, 2018 to May 14, 2018, $29,000 principal amount of convertible promissory notes, including accrued interest, was converted into 5,068,261 unregistered, restricted shares of the Company’s common stock.

Issuances of Promissory Notes to Related Parties

During the period from April 1, 2018 to May 14, 2018, the Company issued promissory notes to George J. Coates and received aggregate cash proceeds of $1,000. During the period from April 1, 2018 to May 14, 2018, the Company issued promissory notes to Bernadette Coates and received aggregate cash proceeds of $11,000. The promissory notes are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly.

Deferred Compensation

During the period from April 1, 2018 to May 14, 2018, George J. Coates, Gregory G. Coates, Barry C. Kaye and one employee agreed to additional deferral of their compensation amounting to $34,000, $10,000, $22,000 and $4,000, respectively.

22

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

THE FOLLOWING DISCUSSION OF OUR PLAN OF OPERATION AND RESULTS OF OPERATIONS SHOULD BE READ IN CONJUNCTION WITH THE FINANCIAL STATEMENTS AND RELATED NOTES TO THE FINANCIAL STATEMENTS INCLUDED ELSEWHERE IN THIS REPORT. THIS DISCUSSION CONTAINS FORWARD-LOOKING STATEMENTS THAT RELATE TO FUTURE EVENTS OR OUR FUTURE FINANCIAL PERFORMANCE. THESE STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS THAT MAY CAUSE OUR ACTUAL RESULTS, LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS TO BE MATERIALLY DIFFERENT FROM ANY FUTURE RESULTS, LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. THESE RISKS AND OTHER FACTORS INCLUDE, AMONG OTHERS, THOSE LISTED UNDER “FORWARD-LOOKING STATEMENTS” AND “RISK FACTORS” INCLUDED IN THE COMPANY’S ANNUAL REPORT ON FORM 10-K FILED WITH THE SECURITIES AND EXCHANGE COMMISSION FOR THE YEAR ENDED DECEMBER 31, 2017. 

Background

We have completed development of the Coates spherical rotary valve engine (“CSRV^®”) system technology. This technology has been successfully applied to natural gas fueled industrial electric power CSRV^® generator engines (“Gen Sets”), automobile engines, residential generators and high-performance racing car engines. We have also designed and retrofitted the CSRV^® system technology into a diesel engine which is suitable for and can be applied to heavy trucks. Provided we can raise sufficient new working capital, we intend to devote a substantial amount of resources during the remainder of 2018 to develop Hydrogen Gen Sets, capable of producing up to 1MW of electrical power output.

We have completed production of an initial next generation 855 cubic inch industrial Gen Set. If we are able to raise sufficient new working capital, we intend to begin ramping up production for sales and distribution to end users. We have not sold any of these Gen Sets to date.

In February 2015, we granted a non-exclusive distribution sublicense to a China-based sales and distribution company that covers distribution in the territory of the Western Hemisphere. Under this sublicense, Renown will be permitted to sell, lease and distribute CSRV^® products. Renown intends to source CSRV^® products from Coates Power, Ltd., a China-based company formed for the purpose of manufacturing CSRV^® products (“Coates Power”). Coates Power has not been able to commence operations due to ongoing delays in obtaining necessary support and approval from the Chinese government in spite of continuing efforts by Renown to do so on its behalf. This has been and continues to be a long, arduous process because the government is addressing this at a very slow pace. We have only received, in prior years, an initial non-refundable deposit of $500,000 towards this license. Until Coates Power can begin production of CSRV^® products for Renown, we will not receive any further monies from our sublicense with Renown.

At this time, as our intellectual property rights only cover the territory of North America, we do not have any rights to enter into a manufacturing and sale license agreement with Coates Power. These rights are currently held by George J. Coates, Gregory G. Coates and The Coates Trust, a trust controlled by George J. Coates. Coates Power and Renown are controlled and managed by Mr. James Pang, the Company’s liaison agent in China.

Independent testing on internal combustion engines incorporating the CSRV^® system technology indicated the following advantages would be derived from this technology:

● Better fuel efficiency

● Reduced harmful emissions

23

Based on more than ten years of operating a Mercedes 300 with an SE 280 engine retrofitted with the CSRV^® system technology, the following advantages were demonstrated:

● Longer intervals between engine servicing, and

● Longer engine life than conventional internal combustion engines.

We continue to be engaged in new research and development activities from time-to-time in connection with applying this technology to other commercially feasible internal combustion engine applications and intend to manufacture engines and/or license the CSRV^® system technology to third party Original Equipment Manufacturers (“OEM’s”) for multiple other applications and uses.

Hydrogen Reactor Technology Owned by George J. Coates

George J. Coates has developed a hydrogen reactor which rearranges H₂O water molecules into HOH molecules also known as Hydroxy-Gas. Hydroxy-Gas has a different molecular structure than hydrogen gas. It consists of two hydrogen atoms. The Hydroxy-Gas produced by the hydrogen reactor can then be harvested for use as a type of gas. Mr. Coates intends to continue with development of this technology to enable the harvested Hydroxy-Gas to be utilized as the fuel source to power our patented CSRV^® engines. We are exploring opportunities with certain third parties to further develop this technology with the objective of bringing it to market. The next phase of this research and development will focus on powering larger, industrial engines. If successful, this application will only require a ready supply of water and would be suitable for stationary engines and generators. Conventional internal combustion engines employing poppet valve assemblies require lubrication and would experience excessive heat and friction if powered with Hydroxy-Gas. This, in turn, would cause the engines to burn out in a rather short period of time. The materials and components of the CSRV^® engines do not require such lubrication and because of their design, are able to operate relatively trouble-free on Hydroxy-Gas as the engine fuel. There can be no assurance that this technology can be developed successfully, or that if developed, it will be feasible to penetrate the internal combustion engine market with this technology.

Applications for patent protection of this technology would be filed upon completion of the research and development. Although at this time no arrangements have been made between us and George J. Coates, owner of the technology, regarding licensing of the hydrogen reactor, Mr. Coates has provided his commitment to license this technology to us once the related patent protection is in place. Accordingly, we do not currently have any rights to manufacture, use, sell and distribute the hydrogen reactor technology, should it become commercially feasible to manufacture and distribute products powered by the Hydroxy-Gas fuel. We have been responsible for all costs incurred to date related to the development of this technology. 

Plan of Operation

Manufacturing, Sales and Distribution

We have completed development of the CSRV^® system technology-based generator engine, including retrofitting a next generation Cummins industrial engine with our CSRV^® engine technology. This unit is being used to attract new licensing transactions and other manufacturing activities. We will need to raise sufficient new working capital to ramp up our own manufacturing and distribution operations.

As discussed above, we plan to primarily devote our resources for the remainder of 2018 to further development of CSRV^® Hydrogen Gen Sets.

We intend to take advantage of the fact that essentially all the parts and components of the CSRV^® generator engine may be readily sourced and acquired from U.S. based suppliers and subcontractors, and, accordingly, expect to manufacture Gen Sets by developing assembly lines within owned manufacturing facilities. The initial limited production will enable us to prove our concept for the CSRV^® system technology and we expect this will dovetail with the existing demand in the marketplace. We plan to address this demand by establishing large scale manufacturing operations in the United States. Transitioning to large scale manufacturing is expected to require a substantial increase in our work force, securing additional manufacturing capacity and substantial capital expenditures.

24

Our ability to establish such manufacturing operations, recruit plant workers, finance initial manufacturing inventories and fund capital expenditures is highly dependent on our ability to successfully raise substantial new working capital in an amount and at a pace which matches our business plans. Potential sources of such new working capital include (i) licensing fees from new sublicensing agreements, (ii) positive working capital generated from sales of our CSRV^® products and (iii) issuance of promissory notes to related parties and issuance of convertible notes. Although we have been successful in raising sufficient working capital to continue our ongoing operations, we have encountered very challenging credit and equity investment markets and have not been able to raise sufficient new working capital to enable us to commence production of our Gen Sets. There can be no assurance that we will be successful in raising adequate new working capital or even any new working capital to carry out our business plans.

Sublicensing

We plan to sublicense the CSRV^® system technology to multiple OEM’s in order to take advantage of third party manufacturers’ existing production capacity and resources by entering into OEM agreements.

Significant Estimates

The preparation of our financial statements in conformity with generally accepted accounting principles in the United States (“GAAP”) requires our management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. These significant estimates include determining the fair value of convertible promissory notes containing embedded derivatives as a result of variable conversion rate provisions, determining a value for Series A Preferred Stock and Series B Convertible Preferred Stock issued in connection with anti-dilution provisions in place, assigning useful lives to our property, plant and equipment, determining an appropriate amount to reserve for obsolete and slow moving inventory, providing a valuation allowance for deferred tax assets, assigning expected lives to and estimating the rate of forfeitures of stock options granted and selecting a volatility factor for the Company’s stock options in order to estimate the fair value of the Company’s stock options on the date of grant. Actual results could differ from those estimates.

Results of Operations for the Three Months Ended March 31, 2018 and 2017

Our principal business activities and efforts during the three months ended March 31, 2018 and 2017 were devoted to (i) applying the CSRV^® system technology to optimally fuel industrial engines with hydrogen gas and (ii) undertaking efforts to raise additional working capital in order to fund ongoing operations.

Although we incurred substantial net losses for the three months ended March 31, 2018 and 2017 of ($1,340,120) and ($847,168), respectively, it is important to consider that a substantial portion of these losses resulted from non-cash expenses required to be recorded for financial reporting purposes in accordance with GAAP. These net losses should be considered in view of the fact that actual cash used in operating activities amounting to ($138,825) and ($144,527) in 2018 and 2017, respectively, was significantly less than these reported net losses. The differences between the reported net losses and actual cash losses incurred in 2018 and 2017 are described in detail in the section “Liquidity and Capital Resources”.

25

Revenue

There were no sales for the three months ended March 31, 2018 and 2017.

Sublicensing fee revenue for the three months ended March 31, 2018 and 2017 amounted to $4,800 and $4,800, respectively. Sublicensing fees are being recognized by amortizing the license deposit of $300,000 on the Canadian License over the approximate remaining life of the last CSRV^® technology patent in force.

Expenses

Research and Development Expenses

There were only limited research and development activities for the three months ended March 31, 2018. For the three months ended March 31, 2017 research and development activities were primarily related to applying the CSRV^® system technology to optimally fuel industrial engines with hydrogen gas. Research and development expenses decreased to $1,489 from $138,387 in 2017, due to a curtailment in research and development activities in the 2018 first quarter period.

Stock-based Compensation Expense

Stock-based compensation expense increased by $398,059 to $589,384 for the three months ended March 31, 2018 from $191,325 for the three months ended March 31, 2017. This increase was primarily due to an increase in issuances of Series B Convertible Preferred Stock to George J. Coates, Gregory G. Coates and Barry C. Kaye, for anti-dilution, partially offset because no shares of Series A Preferred Stock were issued in the 2018 period compared with the issuance of shares of Series A Preferred Stock with an estimated fair value of $17,219 to George J. Coates for anti-dilution in 2017.

Compensation and Benefits

Compensation and benefits increased by $4,590 to $136,337 for the three months ended March 31, 2018 from $131,747 for the three months ended March 31, 2017. This increase was primarily due to an $29,100 decrease in the amount of compensation allocated from compensation and benefits expense to research and development costs in the 2018 period, partially offset by the reduction in 2018 from the retirement of Bernadette Coates and a reduction in other compensation costs.

General and Administrative Expenses

General and administrative expenses increased by $3,875 to $122,714 for the three months ended March 31, 2018 from $118,839 for the three months ended March 31, 2017. This net increase in 2018 resulted from increases in legal and professional fees of $6,926, property taxes of $4,725 and building expenses of $4,511, partially offset by decreases in utilities of ($4,996), miscellaneous expenses of ($3,662), financing costs of ($2,820) and all other expenses, net of ($809).

Depreciation and Amortization

Depreciation and amortization expense decreased to $11,007 for the three months ended March 31, 2018 from $12,249 for the three months ended March 31, 2017.

Loss from Operations

A loss from operations of ($856,131) was incurred for the three months ended March 31, 2018 compared with a loss from operations of ($587,747) for the three months ended March 31, 2017. The $268,384 increase in the amount of the loss from operations in 2018 was primarily attributable to the increase in non-cash, stock-based compensation expense of $398,059, partially offset by the ($136,898) decrease in research and development costs.

26

Other Expenses

Increase in Estimated Fair Value of Embedded Derivative Liabilities

The estimated fair value of embedded derivative liabilities, which relates to outstanding convertible promissory notes, is remeasured at each balance sheet date. For the three months ended March 31, 2018 and 2017, other expense was recorded to reflect the increase in the fair value of embedded derivative liabilities of ($137,708) and ($51,277), respectively.

Loss on conversion of convertible notes

For the three months ended March 31, 2018 and 2017, the Company realized a non-cash loss on conversion of convertible notes of ($20,679) and ($11,629), respectively.

Interest Expense

Interest expense increased to ($325,602) for the three months ended March 31, 2018 from ($196,515) in 2017. Interest expense in 2018 consisted of non-cash interest related to convertible promissory notes of $228,174, interest on amounts due to related parties of $71,809, mortgage loan interest of $23,786 and net other interest of $1,833.

Interest expense in 2017 consisted of non-cash interest related to convertible promissory notes of $90,070, interest on amounts due to related parties of $64,462, mortgage loan interest of $33,475 and net other interest of $8,508.

Deferred Taxes

For the three months ended March 31, 2018 and 2017, the change in deferred taxes was fully offset by a valuation allowance, resulting in a $-0- net income tax provision.

Net Loss

For the three months ended March 31, 2018, we incurred a net loss of ($1,340,120) or ($0.03) basic net loss per share, as compared with net loss of ($847,168) or ($0.05) basic net loss per share for the three months ended March 31, 2017. The increase in the amount of the net loss was primarily attributable to an increase in non-cash, stock-based compensation expense of $398,059, an increase in the estimated fair value of embedded derivative liabilities of $86,431 and an increase in interest expense of $129,087, partly offset by a ($136,898) decrease in research and development costs.

Liquidity and Capital Resources

Our cash position at March 31, 2018 was $48,896, an increase of $41,689 from the cash position of $6,807 at December 31, 2017. We had negative working capital of ($7,786,238) at March 31, 2018, which represents a decrease in our working capital of ($319,239) compared to the ($7,466,999) of negative working capital at December 31, 2017. Our current liabilities of $7,987,343 at March 31, 2018, increased by $409,319 from $7,578,024 at December 31, 2017. This net increase resulted from (i) a $179,226 increase in the carrying amount of convertible promissory notes, net of unamortized discount, (ii) a $137,708 net increase in the derivative liability related to convertible promissory notes (iii) a $116,900 increase in accounts payable and accrued liabilities, (iv) an $87,010 increase in deferred compensation payable, partially offset by (v) repayment of ($55,000) of promissory notes to related parties, (vi) a $41,525 decrease in the current portion of sublicense deposits and (vii) repayment of ($15,000) of principal of the mortgage loan payable.

The major outlays of cash during the three months ended March 31, 2018 and 2017 were for repayments of principal and interest on the mortgage loan, repayments of loans from related parties, patent maintenance expenses, employee compensation and benefits, legal and professional fees, property taxes, financing costs, investors relations expenses and other general and administrative expenses.

27

Net Cash Flows Used in Operating Activities

Operating activities utilized cash of ($138,825) for the three months ended March 31, 2018, a decrease of $5,702 from the cash utilized for operating activities of ($144,527) for the three months ended March 31, 2017. Cash utilized by operating activities in the three months ended March 31, 2018 resulted from (i) a cash basis net loss of ($285,759), after adding back (deducting) non-cash stock-based compensation expense of $589,384, interest accrued, but not paid of $300,384, an increase in embedded derivative liabilities related to convertible notes of $137,708, a non-cash loss on conversion of convertible notes of $20,679, depreciation and amortization of $11,007 and non-cash licensing revenues of ($4,800) and (ii) changes in current assets and liabilities, including a decrease in inventory of $1,446, an increase in other assets of ($49,839), an increase of $108,316 in accounts payable and accrued liabilities and an increase in deferred compensation payable of $87,010.

Net Cash Used in Investing Activities

No cash was used in investing activities for the three months ended March 31, 2018 and 2017.

Net Cash Provided by Financing Activities

Cash provided by financing activities for the three months ended March 31, 2018, amounted to $184,766, an increase of $46,847 from the cash provided by financing activities of $137,919 for the three months ended March 31, 2017. This was comprised of proceeds from issuances of convertible promissory notes aggregating $265,000, partially offset by partial repayments of principal and interest on promissory notes to related parties of ($65,434) and principal repayments of ($15,000) on a mortgage loan payable.

Going Concern

We have incurred net recurring losses since inception, amounting to an accumulated deficit of ($75,053,330) as of March 31, 2018 and had a stockholders’ deficiency of ($6,375,828). In addition, our mortgage loan which had a principal balance of $1,258,000 at March 31, 2018, matures in July 2018. The Company will be required to renegotiate the terms of an extension of the mortgage loan or successfully refinance the property with another mortgage lender, if possible. Failure to do so could adversely affect the Company’s financial position and results of operations. Further, the recent trading price range of the Company’s common stock has introduced additional risk and difficulty to the Company’s challenge to secure needed additional working capital. We will need to obtain additional working capital in order to continue to cover our ongoing cash expenses.

These factors raise substantial doubt about our ability to continue as a going concern. Our Independent Registered Public Accountants have stated in their Auditor’s Report dated April 17, 2018, with respect to our financial statements as of and for the year ended December 31, 2017, that these circumstances raise substantial doubt about our ability to continue as a going concern.

During 2018, we restricted variable costs to only those expenses that are necessary to perform activities related to efforts to negotiate sublicenses for distribution of our CSRV^® products, raising working capital to enable us to commence limited production of our CSRV^® system technology products, research and development and general and administrative costs in support of such activities.

Our financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

28

Potential sources of working capital and new funding being pursued by us include (i) issuances of promissory notes to related parties and convertible promissory notes, (ii) licensing fees for hydrogen powered CSRV^® industrial generators, (iii) new equity investments, (iv) new borrowing arrangements and (v) proceeds from sales of CSRV^® Gen Sets. There can be no assurance that we will be successful in securing any of these sources of additional funding. In this event, we may be required to substantially or completely curtail our operations, which could have a material adverse effect on our operations and financial condition.

At March 31, 2018, current liabilities amounted to $7,987,343, comprised of deferred compensation of $1,708,332, promissory notes due to related parties aggregating $1,417,409, legal and professional fees of $1,396,357, mortgage loan amounting to $1,258,158, accrued interest expense of $621,740, accrued general and administrative expenses of $527,947, a derivative liability related to convertible promissory notes of $496,704, convertible promissory notes, net of unamortized discount of $276,042, unearned revenues of $150,595, accrued research and development expenses of $114,859 and the current portion of license deposits of $19,200.

Contractual Obligations and Commitments

The following table summarizes our contractual obligations and commitments at March 31, 2018:

	Total		2018		2019
Deferred compensation	$	1,708,332	$	1,708,332	$	-
Promissory notes to related parties		1,417,409		1,417,409		-
Mortgage loan payable		1,258,158		1,258,158		-
Convertible promissory notes		392,551		340,051		52,500
Total	$	4,776,450	$	4,723,950	$	52,500

Critical Accounting Policies

Our significant accounting policies are presented in the notes to our financial statements for the period ended March 31, 2018, which are contained in this filing and notes to financial statements for the year ended December 31, 2017, which are contained in our 2017 Annual Report on Form 10-K. The significant accounting policies that are most critical and aid in fully understanding and evaluating the reported financial results include the following:

We prepare our financial statements in conformity with GAAP. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the board of directors; however, actual results could differ from those estimates.

Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment whenever facts and circumstances indicate that the carrying value may not be recoverable.  When required, impairment losses on assets to be held and used are recognized based on the fair value of the asset.  The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required.  If the carrying amount of the long-lived asset is not recoverable from its undiscounted cash flows, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset.  When fair values are not available, we estimate fair value using the expected future cash flows discounted at a rate commensurate with the risk associated with the recovery of the assets. We did not recognize any impairment losses for any periods presented.

29

Other significant estimates include determining the fair value of convertible promissory notes containing embedded derivatives and variable conversion rates, determining a value for Series A Preferred Stock and Series B Convertible Preferred Stock issued, assigning useful lives to the Company’s property, plant and equipment, determining an appropriate amount to reserve for obsolete and slow moving inventory, estimating a valuation allowance for deferred tax assets, assigning expected lives to, and estimating the rate of forfeitures of, stock options granted and selecting a trading price volatility factor for the Company’s common stock in order to estimate the fair value of the Company’s stock options on the date of grant or other appropriate measurement date. Actual results could differ from those estimates.

New Accounting Pronouncements

Revenue Recognition

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled to when products are transferred to customers. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606) – Deferral of the Effective Date, which defers the effective date of ASU 2014-09 for one year and permits early adoption as early as the original effective date. Accordingly, we may adopt the standard in either its first quarter of 2018 or 2019.

In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606) – Identifying Performance Obligations and Licensing (“ASU 2016-10”), which amends the guidance in ASU 2014-09 related to identifying performance obligations and accounting for licenses of intellectual property. We will adopt ASU 2016-10 with ASU 2014-09. We are currently evaluating the impact of adopting the new revenue recognition standard, as amended, but do not expect it to have a material impact on our financial statements.

Stock Compensation

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard, but do not expect it to have a material impact on our financial statements.

Financial Instruments

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10) (“ASU 2016-01”), which updates certain aspects of recognition, measurement, presentation and disclosure of financial instruments. ASU 2016-01 will be effective for the Company beginning in our first quarter of 2019. We do not believe adoption of the new financial instruments standard will have a material impact on our financial statements.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements. 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are not required to provide the information under this item as we are a smaller reporting company.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (the “Exchange Act”), we carried out an evaluation, with the participation of our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) (our principal financial and accounting officer), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

30

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are currently not involved in any litigation that we believe could have a materially adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our company's or our company's subsidiaries' officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

Item 1A. Risk Factors

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our 2017 Annual Report on Form 10-K filed April 17, 2018.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following issuances of securities during the three months ended March 31, 2018 were exempt from registration pursuant to Section 4(2), Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and Section 3(a)10 of the Securities Act. We made this determination based on the representations of the Investors which included, in pertinent part, that such Investors were “accredited investors” within the meaning of Rule 501 of Regulation D promulgated under the Securities Act, and that such Investors were acquiring our common stock for investment purposes for their own respective accounts and not as nominees or agents, and not with a view to the resale or distribution thereof, and that the Investors understood that the shares of our common stock may not be sold or otherwise disposed of without registration under the Securities Act or an applicable exemption therefrom. 

In a series of transactions, convertible promissory notes with an aggregate principal balance of $82,000, including accrued interest thereon were converted into 8,357,452 unregistered shares of common stock.

The net proceeds from the original issuances of convertible promissory notes was used for general working capital purposes.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

31

Item 5. Other Information

Certificate of Validation

On April 2, 2018, the Company filed a certificate of validation with the state of Delaware which had retroactive effect to the close of trading in the Corporation’s common stock on December 1, 2017, in order to:

(i) cure certain technical, procedural defects related to the 1:200 reverse stock split, which became effective at the close of trading on December 31, 2017,

(ii) clarify that the reverse stock split effected a 1:200 reduction in the number of the Corporation’s authorized shares of common stock, from 12,000,000,000 to 60,000,000, with retroactive effect to the close of trading on December 1, 2017,

(iii) clarify that the reverse stock split effected 1:200 reduction in the number of authorized shares of the Corporation’s preferred stock, from 100,000,000 to 500,000 with retroactive effect to the close of trading on December 1, 2017; and,

(iv) concurrently therewith, further amend the Corporation’s Amended Certificate of Articles of Incorporation with the State of Delaware to increase the number of the Corporation’s authorized shares of common stock, par value $0.0001 from 60,000,000 to 120,000,000 and reduce the number of authorized shares of the Corporation’s preferred stock, par value $0.001 from 500,000 to 350,000.

The above corporate action was authorized by the board of directors on February 28, 2018, and by means of obtaining the written consent of George J. Coates, the sole majority stockholder, was approved by the shareholders on March 1, 2018.

Certificate of Conversion and Certificate of Designation

On May 9, 2018, the Company filed a Certificate of Conversion and a Certificate of Designation which caused the following corporate actions to become effective:

(i) The Corporation’s State of Domicile was converted from the State of Delaware to the State of Nevada.

(ii) The number of authorized shares of capital stock of the Company was increased to:

a. 2,400,000,000 shares of common stock, par value $0.0001 per share

b. 100,000,000 shares of preferred stock, par value $0.001 per share

(iii) The series and number of shares of preferred stock designated from the 100,000,000 shares of preferred stock authorized, was increased to:

a. 1,000,000 shares of Series A Preferred Stock, $0.001 per share

b. 10,000,000 shares of Series B Convertible Preferred Stock, $0.001 per share

Item 6. Exhibits

Exhibit Number	Description
3.1*	Certificate of Conversion from a Delaware Corporation to a Nevada Corporation, as filed with the Secretary of State of Nevada. on May 9, 2018
3.2*	Articles of Incorporation, as filed with the Secretary of State of Nevada on May 9, 2018.
3.3*	Certificate of Designation of Preferred Stock, as filed with the Secretary of State of Nevada on May 9, 2018.
3.4*	By-Laws of Coates International, Ltd., dated May 9, 2018.
31.1*	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Schema
101.CAL*	XBRL Taxonomy Calculation Linkbase
101.DEF*	XBRL Taxonomy Definition Linkbase
101.LAB*	XBRL Taxonomy Label Linkbase
101.PRE*	XBRL Taxonomy Presentation Linkbase
101.DE*	XBRL Taxonomy Extension Definition Linkbase Document

*Filed herewith.

**Furnished herewith. 

32

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	COATES INTERNATIONAL, LTD.
Date: May 14, 2018	/s/ George J. Coates
	George J. Coates
	Duly Authorized Officer, President and Chief Executive Officer (Principal Executive Officer)

Date: May 14, 2018	/s/ Barry C. Kaye
	Barry C. Kaye
	Duly Authorized Officer, Treasurer and Chief Financial Officer (Principal Financial Officer)

33

EX-3.1

EX-3.2

EX-3.3

EX-3.4

EXHIBIT 3.4

BY-LAWS OF

COATES INTERNATIONAL, LTD.

A Nevada corporation

May 9, 2018

ARTICLE I

MEETINGS OF STOCKHOLDERS

Section 1.  Annual Meeting. The annual meeting of the stockholders of Coates International, Ltd. (the “Corporation”) for the election of directors and for the transaction of such other business as may come before the meeting shall be on the third Monday of April of each year, if not a legal holiday, and if a legal holiday, then on the next succeeding day not a legal holiday, at such time and at such location as shall be designated by the Board of Directors or at such other date, time, and location as the Board of Directors shall designate. Notwithstanding the foregoing, the annual meeting may be waived by a majority of stockholders representing a majority of the votes eligible to vote at a meeting of stockholders on matters brought before the stockholders for a vote.

Section 2.  Special Meetings. Special meetings of the stockholders, unless otherwise prescribed by statute, may be called at any time by the Board or the President.

Section 3.  Notice of Meetings. Notice of the place, date and time of the holding of each annual and special meeting of the stockholders and, in the case of a special meeting, the purpose or purposes thereof, shall be given personally or by mail in a postage prepaid envelope to each stockholder entitled to vote at such meeting, not less than ten nor more than sixty days before the date of such meeting, and, if mailed, shall be directed to such stockholder at his address as it appears on the records of the Corporation, unless he shall have filed with the Secretary of the Corporation a written request that notices to him be mailed to some other address, in which case it shall be directed to him at such other address. Notice of any meeting of stockholders shall not be required to be given to any stockholder who shall attend such meeting in person or by proxy and who shall not, at the beginning of such meeting, object to the transaction of any business because the meeting is not lawfully called or convened, or who shall, either before or after the meeting, submit a signed waiver of notice, in person or by proxy. Unless the Board of Directors shall fix, after the adjournment, a new record date for an adjourned meeting, notice of such adjourned meeting need not be given if the time and place to which the meeting shall be adjourned were announced at the meeting at which the adjournment is taken. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

1 | Page

Section 4.  Place of Meetings. Meetings of the stockholders may be held at such place, within or without the State of Nevada, as the Board of Directors or the officer calling the same shall specify in the notice of such meeting, or in a duly executed waiver of notice thereof.

Section 5.  Quorum. At all meetings of the stockholders the holders of a majority of the votes of the shares of stock of the Corporation issued and outstanding and entitled to vote shall be present in person or by proxy to constitute a quorum for the transaction of any business, except when stockholders are required to vote by class, in which event a majority of the issued and outstanding shares of the appropriate class shall be present in person or by proxy, or except as otherwise provided by statute or in the Certificate of Incorporation. In the absence of a quorum, the holders of a majority of the shares of stock present in person or by proxy and entitled to vote, or if no stockholder entitled to vote is present, then any officers of the Corporation may adjourn the meeting from time to time. At any such adjourned meeting at which a quorum may be present any business may be transacted which might have been transacted at the meeting as originally called.

Section 5.  Organization. At each meeting of the stockholders, the President, or in his absence or inability to act, any person chosen by a majority of those stockholders, present, in person or by proxy and entitled to vote, shall act as chairman of the meeting. The secretary, or in his absence or inability to act, any person appointed by the chairman of the meeting, shall act as secretary of the meeting keep the minutes thereof.

Section 7.  Order of Business. Except as otherwise provided by statute, by the Certificate of Incorporation, or by any certificate duly filed in the State of Nevada pursuant to Nevada General Corporation Law, each holder of record of shares of Common Stock of the Corporation shall be entitled to one vote per share. Each holder of record of shares of Preferred Stock shall be entitled to the number of votes stipulated in any Certificate of Designation authorized by a duly adopted resolution of the board of directors and duly filed with the Secretary of State of the state of Nevada. Stockholders entitled to vote shall be determined on the date fixed by the Board of Directors as the record date for the determination of the stockholders who shall be entitled to notice of and to vote at such meeting; or if such record date shall not have been so fixed, then at the close of business on the day next preceding the date on which notice thereof shall be given, or if notice is waived, at the close of business on the day next preceding the day on which the meeting is held; or each stockholder entitled to vote at any meeting of stockholders may authorize another person or persons to act for him by a proxy signed by such stockholder or his attorney-in-fact. Any such proxy shall be delivered to the secretary of such meeting at or prior to the time designated in the order of business for so delivering such proxies. No proxy shall be valid after the expiration of three years from the date thereof, unless otherwise provided in the proxy. Every proxy shall be revocable at the pleasure of the stockholder executing it, except in those cases where an irrevocable proxy is permitted by law. Except as otherwise provided by statute, these By-Laws, or the Certificate of Incorporation, any corporate action to be taken by vote of the stockholders shall be authorized by majority of the total votes, or when stockholders are required to vote by class by a majority of the votes of the appropriate class, cast at a meeting of stockholders by the holders of shares present in person or represented by proxy and entitled to vote on such action. Unless required by statute or determined by the chairman of the meeting to be advisable, the vote on any question need not be by written ballot. On a vote by written ballot, each ballot shall be signed by the stockholder voting, or by his proxy, if there by such proxy, and shall state the number of shares voted.

2 | Page

Section 9.  List of Stockholders. The officer who has charge of the stock ledger of the Corporation shall prepare and make, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or if not so specified, at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting during the whole time thereof and may be inspected by any stockholder who is present.

Section 10.  Inspectors. The Board of Directors may, in advance of any meeting of stockholders, appoint one or more inspectors to act at such meeting or any adjournment thereof. If the inspectors shall not be so appointed or if any of them fail to appear or act, the chairman of the meeting may, and on the request of any stockholder entitled to vote thereat appoint inspectors. Each inspector, before entering upon the discharge of his duties, shall take and sign an oath faithfully to execute the duties of inspector at such meeting with strict impartiality and according to the best of his ability. The inspectors shall determine, the number of shares represented at the meeting, the existence of a quorum, the validity and effect of proxies, and shall receive votes, ballots or consents, hear and determine all challenges and questions arising in connection with the right to vote, count and tabulate all votes, ballots or consents, hear and determine all challenges and questions arising in connection with the right to vote, count and tabulate all votes, ballots or consents, determine the result, and do such acts as are proper to conduct the election or vote with fairness to all stockholders. On request of the chairman of the meeting or any stockholder entitled to vote thereat, the inspectors shall make a report in writing of any challenge, request or matter determined by the inspection and shall execute a certificate of any fact found by them. No director or candidate for the office of director shall act as inspector of an election of directors. Inspectors need not be stockholders.

Section 11.  Consent of Stockholder in Lieu of Meeting. Whenever the vote of stockholders at a meeting thereof is required or permitted to be taken for or in connection with any corporate action, the meeting and vote of stockholders can be dispensed with: (1) if all of the stockholders who would have been entitled to vote upon the action if such meeting were held shall consent in writing to such corporate action being taken; or (2) unless the Certificate of Incorporation provides otherwise, with the written consent of the holders of not less than the minimum percentage of the total vote required by statute for the proposed corporate action, and provided that prompt notice must be given to all stockholders not signing such written consent of the taking of corporate action without a meeting and by less than unanimous written consent.

3 | Page

ARTICLE II

BOARD OF DIRECTORS

Section 1.  General Power. The business and affairs of the corporation shall be managed by the Board of Directors. The Board of Directors may exercise all such authority and powers of the Corporation and do all such lawful acts and things as are not by statute or the Certificate of Incorporation directed or required to be exercised or done by the stockholders.

Section 2.  Number, Qualifications, Election, and Term of Office. The number of directors of the Corporation shall be six but, by vote of a majority of the entire Board or amendment of these By-Laws, the number thereof may be increased or decreased as may be so provided, subject to the provisions of Section 11 of this Article II. All of the directors shall be at least twenty-one (21) years of age. Directors need not be stockholders. Except as otherwise provided by statute or these By-Laws, the directors shall be elected at the annual meeting of the stockholders for the election of directors at which a quorum is present, and the persons receiving a plurality of the votes cast at such election shall be elected. Each director shall hold office until the next annual meeting of the stockholders and until his successor shall have been duly elected and qualified or until his death, or until he shall have resigned, or have been removed, as hereinafter provided by statute or the Certificate of Incorporation.

Section 3.  Place of Meeting. Meetings of the Board of Directors may be held at such place, within or without the State of Nevada, as the Board of Directors may from time to time determine or shall be specified in the notice of waiver of notice of such meeting.

Section 4.  First Meeting. The Board of Directors shall meet for the purpose of organization, the election of officers, and the transaction of other business, as soon as practicable after each annual meeting of the stockholders, on the same day and at the same place where such annual meeting shall be held. Notice of such meeting need not be given. Such meeting may be held at any other time or place (within or without the State of Nevada which shall be specified in a notice thereof given as hereinafter provided in Section 7 of this Article II.

Section 5.  Regular Meetings. Regular meetings of the Board of Directors shall be held quarterly at such place as the Board of Directors may from time to time determine. If any day fixed for a regular meeting shall be a legal holiday at the place where the meeting is to be held, then the meeting which would otherwise be held on that day shall be held at the same hour on the next succeeding business day. Notice of regular meetings of the Board of Directors need not be given except as otherwise required by statute or these By-Laws. At the discretion of the duly elected Chairman of the Board, quarterly regular meeting may be waived if there is no new business to be conducted at any such regular meeting.

4 | Page

Section 6.  Special Meetings. Special meetings of the Board of Directors may be called by one or more directors of the Corporation or by the President.

Section 7.  Notice of Meetings. Notice of each special meeting of the Board of Directors (and of each regular meeting for which notice shall be required) shall be given by the Secretary as hereinafter provided in this Section 7, in which notice shall be stated the time and place of the meeting. Notice of each such meeting shall be delivered to each director either personally or by telephone or email, at least twenty-four (24) hours before the time at which such meeting is to be held or by first-class mail, postage prepaid, addressed to him at his residence, or usual place of business, at least three days before the day on which such meeting is to be held. Notice of any such meeting need not be given to any director who shall, either before or after the meeting submit a signed waiver of the lack of notice to him, who shall attend such meeting without protesting, prior to or at its commencement. Except as otherwise specifically required by these By- Laws, a notice or waiver of notice of any regular or special meeting need not state the purpose of such meeting.

Section 8.  Quorum and Manner of Acting. A majority of the entire Board of Directors shall be present in person at any meeting of the Board of Directors in order to constitute a quorum for the transaction of business at such meeting, and, except as otherwise expressly required by statute or the Certificate of Incorporation the act of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board of Directors, a majority of the directors present thereat, or if no director be present, the Secretary, may adjourn such meeting to another time and place, or such meeting, unless it be the first meeting of the Board of Directors, need not be held. At any adjourned meeting at which a quorum is present, any business may be transacted which might have been transacted at the meeting as originally called. Except as provided in Article III of these By-Laws, the directors shall act only as a Board and the individual directors shall have no power as such.

Section 9.  Organization. At each meeting of the Board of Directors, the President, or, in his absence or inability to act, another director chosen by a majority of the directors present, shall act as chairman of the meeting and preside thereat. The Secretary (or, in his absence or inability to act, any person appointed by the chairman) shall act as secretary of the meeting keep the minutes thereto.

5 | Page

Section 10.  Resignations. Any director of the Corporation may resign at any time by giving written notice of his resignation to the Board of Directors or the President or the Secretary. Any such resignation shall take effect at the time specified therein or, if the time when it shall become effective shall not be specified therein, the acceptance of such resignation shall not be necessary to make it effective.

Section 11.  Vacancies. Vacancies may be filled by a majority of the directors then in office, through less than a quorum, or by a sole remaining director, and the directors so chosen shall hold office until the next annual election and until their successors are duly elected and shall qualify, unless sooner displaced, if there are no directors in office, then an election of directors may be held in the manner provided by statute. If, at the time of filling any vacancy or any newly created directorship, the directors then in office shall constitute less than a majority of the whole Board (as constituted immediately prior to any such increase), the Nevada Business Court having jurisdiction may, upon application of any stockholder or holders of at least ten percent of the votes of the shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office. Except as otherwise provided in these By-Laws, when one or more directors shall resign from the Board of Directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have the power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold office as provided in this section for the filling of other vacancies.

Section 12.  Removal of Directors. Except as otherwise provided in the Certificate of Incorporation or in these By-Laws, any director may be removed, either with or without cause, at any time, by the affirmative vote of a majority of the votes of the issued and outstanding stock entitled to vote for the election of directors of the Corporation given at a special meeting of the stockholders called and held for that purpose; and the vacancy in the Board of Directors caused by any such removal may be filled by such stockholders at such meeting, or, if the stockholders shall fail to fill such vacancy, as provided in these By-Laws. Notwithstanding the foregoing, a director my be removed by written consent by the stockholders that would otherwise have been entitled to the majority of the eligible votes at a meeting of stockholders to vote on such removal, in lieu of a special meeting stockholders.

6 | Page

Section 13.  Action Without Meeting. Any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting if all members of the Board of Directors or committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of the Board of Directors or committee.

ARTICLE III

COMMITTEES

Section 1.  Committees. The Board of Directors may, by resolution passed by a majority of the whole Board of Directors, designate one or more committees, each committee to consist of one or more of the directors of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent permitted by law and to the extent provided in the resolution of the Board of Directors, shall have the right to exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it.

Section 2.  Committee Rules. Unless the Board of Directors provides otherwise, each committee designated by the Board of Directors may make, alter and repeal rules for the conduct of its business. In the absence of such rules each committee shall conduct its business in the same manner as the Board of Directors conducts its business pursuant to Article II of these By-Laws.

7 | Page

ARTICLE IV

OFFICERS

Section 1.  Number and Qualifications. The officers of the Corporation shall be the President, Secretary, and Treasurer. Any two or more offices may be held by the same person. Such officers shall be elected from time to time by the Board of Directors, each to hold office until the meeting of the Board of Directors following the next annual meeting of the stockholders, or until his successor shall have been duly elected and shall have qualified, or until his death, or until he shall have resigned, or have been removed, as hereinafter provided in these By-Laws. The Board of Directors may from time to time elect, or the President may appoint, such other officers (including one or more Vice-Presidents, Assistant Secretaries, and Assistant Treasurers), and such agents, as may be necessary or desirable for the business of the Corporation. Such other officers and agents shall have such duties and shall hold their offices for such terms as may be prescribed by the Board of Directors or by the appointing authority.

Section 2.  Resignations. Any officer of the Corporation may resign at any time by giving written notice of his resignation to the Board of Directors, the President or the Secretary. Any such resignation shall take effect at the time specified therein or, if the time when it shall become effective shall not be specified therein, immediately upon its receipt; and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.

Section 3.  Removal. Any officer or agent of the Corporation may be removed, either with or without cause, at any time, by the vote of the majority of the entire Board of Directors at any meeting of the Board of Directors, or, except in the case of an officer or agent elected or appointed by the Board of Directors, by the President. Such removal shall be without prejudice to the contractual rights, if any, of the person so removed.

Section 4.  Vacancies. A vacancy in any office, whether arising from death, resignation, removal or any other cause, may be filled for the unexpired portion of the term of the office which shall be vacant, in the manner prescribed in these By-Laws for the regular election or appointment of such office.

Section 5.  Officers’ Bonds or Other Security. If required by the Board of Directors, any officer of the Corporation shall give a bond or other security for the faithful performance of his duties, in such amount and with such surety or sureties as the Board of Directors may require.

Section 6.  Compensation. The compensation of the officers of the Corporation for their services as such officers shall be fixed from time to time by the Board of Directors; provided, however, that the Board of Directors may delegate to the President the power to fix the compensation of officers and agents appointed by the President. An Officer of the Corporation shall not be prevented from receiving compensation by reason of the fact that he is also a director of the Corporation.

8 | Page

Section 7.  President. The President shall be the chief executive officer of the Corporation and shall have the general and active management of the business of the Corporation and general and active supervision and direction over the other officers, agents and employees and shall see that their duties are properly performed. He shall, if present, preside at each meeting of the Stockholders and of the Board of Directors and shall be an ex officio member of all committees of the Board of Directors. He shall perform all duties incident to the office of President and Chief Executive Office and such other duties as may from time to time be assigned to him by the Board of Directors.

Section 8.  Secretary. The Secretary shall:

(a) Keep or cause to be kept in one or more books provided for that purpose, the minutes of the meetings of the Board of Directors, the committees of the Board of Directors and the stockholders;

(b) See that all notices are duly given in accordance with the provisions of these By-Laws and as required by law;

(c) Be custodian of the records and the seal of the Corporation and affix and attest the seal to all stock certificates of the Corporation (unless the seal of the Corporation on such certificates shall be a facsimile, as hereinafter provided) and affix and attest the seal to all other documents to be executed on behalf of the Corporation under its seal;

(d) Ensure that the books, reports, statements, certificates and other documents and records required by law to be kept and filed are properly kept and filed; and

(e) In general, perform all the duties incident to the office of Secretary and such other duties as from time-to-time may be assigned to him by the Board of Directors or the President.

Section 9. Treasurer. The Treasurer shall be the chief financial officer of the Corporation and shall exercise general supervision over the receipt, custody, and disbursements of corporate funds. He shall have such further powers and duties as may be conferred upon him from time to time by the President or the Board of Directors.

9 | Page

ARTICLE V

INDEMNIFICATION

The Corporation, by action of the Board of Directors, may, to the fullest extent permitted by the General Corporation Law of the State of Nevada, indemnify any and all persons who it shall have power to indemnify against any and all of the expenses, liabilities, or other matters for which indemnification may be available.

ARTICLE VI

FISCAL YEAR

The fiscal year of the Corporation shall begin on the first day of January of each year and end on the last day of December of such year.

ARTICLE VII

SEAL

The Board of Directors shall provide a corporate seal, which shall be in the form of the name of the Corporation and the words and figures “Corporate Seal 1991, Nevada”.

ARTICLE VIII

AMENDMENTS

These By-Laws may be amended or repealed, or new By-Laws may be adopted, (1) at any annual or special meeting of the stockholders, by a majority of the total votes of the stockholders, present or in person or represented by proxy and entitled to vote on such action; provided, however, that the notice of such meeting shall have been given as provided in these By-Laws, or the adoption of new By-Laws, is one of the purposes of such meeting; (2) by written consent of the stockholders pursuant to Section II of Article I; or (3) by action of the Board of Directors.

I, the undersigned, Secretary of the Corporation, do hereby certify that the foregoing is a true, complete, and accurate copy of the By-Laws of Coates International, Ltd., duly adopted by unanimous written consent of the Board of Directors of the 7^th day of May, 2018, and I do further certify that these By-Laws have not since been altered, amended, repealed, or rescinded, and are now in full force and effect.

/s/ Gregory G. Coates

Gregory G. Coates

Secretary

10 | Page

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, George J. Coates, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Coates International, Ltd. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)       Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 14, 2018	/s/ George J. Coates
	George J. Coates
	President and Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Barry C. Kaye, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Coates International, Ltd. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)       Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 14, 2018	/s/ Barry C. Kaye
	Barry C. Kaye
	Chief Financial Officer (Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report of Coates International, Ltd. (the “Company”) on Form 10-Q for the period ended March 31, 2018 (the “Report”), I, George J. Coates, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.       The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.       The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 14, 2018	/s/ George J. Coates
	George J. Coates
	President and Chief Executive Officer (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report of Coates International, Ltd. (the “Company”) on Form 10-Q for the period ended March 31, 2018 (the “Report”), I, Barry C. Kaye, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.       The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.       The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 14, 2018	/s/ Barry C. Kaye
	Barry C. Kaye
	Treasurer and Chief Financial Officer (Principal Financial Officer)

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 14, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	COATES INTERNATIONAL LTD \DE\
Entity Central Index Key	0000948426
Amendment Flag	false
Trading Symbol	COTE
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		59,338,954

XML

Balance Sheets - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current Assets
Cash	$ 48,496	$ 6,807
Inventory	102,163	103,610
Other current assets	50,446	608
Total Current Assets	201,105	111,025
Property, plant and equipment, net	2,022,299	2,031,684
Deferred licensing costs, net	32,811	33,882
Total Assets	2,256,215	2,176,591
Current Liabilities
Accounts payable and accrued liabilities	2,660,903	2,544,003
Deferred compensation payable	1,708,332	1,621,322
Promissory notes to related parties	1,417,409	1,472,409
Mortgage loan payable	1,258,158	1,273,158
Derivative liability related to convertible promissory notes	496,704	358,996
Convertible promissory notes, net of unamortized discount	276,042	96,816
Unearned revenues	150,595	150,595
Sublicense deposits	19,200	60,725
Total Current Liabilities	7,987,343	7,578,024
Non-current portion of sublicense deposits	644,700	607,975
Total Liabilities	8,632,043	8,185,999
Commitments and Contingencies
Stockholders' Deficiency
Preferred stock, $0.001 par value, 350,000 shares authorized:
Series A Preferred Stock, 5,000 shares designated, 3,601 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	4	4
Series B Convertible Preferred Stock, 345,000 shares designated, 281,378 and 228,471 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	281	228
Common Stock, $0.0001 par value, 120,000 shares authorized, 45,300,694 and 36,943,242 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	4,530	3,694
Additional paid-in capital	68,672,687	67,699,876
Accumulated deficit	(75,053,330)	(73,713,210)
Total Stockholders' Deficiency	(6,375,828)	(6,009,408)
Total Liabilities and Stockholders' Deficiency	$ 2,256,215	$ 2,176,591

XML

Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized shares	350,000	350,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized shares	120,000	120,000
Common stock, issued shares	45,300,694	36,943,242
Common stock, outstanding shares	45,300,694	36,943,242
Series A Preferred Stock
Series A preferred stock, designated shares	5,000	5,000
Series A Preferred stock, issued shares	3,601	3,601
Series A Preferred stock, outstanding shares	3,601	3,601
Series B Convertible Preferred Stock
Series B convertible preferred stock, designated shares	345,000	345,000
Series B Preferred stock, issued shares	281,378	228,471
Series B Preferred stock, outstanding shares	281,378	228,471

XML

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Statements of Operations [Abstract]
Sublicensing fee revenue	$ 4,800	$ 4,800
Total Revenues	4,800	4,800
Expenses:
Research and development costs	1,489	138,387
Stock-based compensation expense	589,384	191,325
Compensation and benefits	136,337	131,747
General and administrative expenses	122,704	118,839
Depreciation and amortization	11,007	12,249
Total Operating Expenses	860,931	592,547
Loss from Operations	(856,131)	(587,747)
Other Expenses:
Increase in estimated fair value of embedded derivative liabilities	(137,708)	(51,277)
Loss on conversion of convertible notes	(20,679)	(11,629)
Interest expense, net	(325,602)	(196,515)
Total other expenses	(483,989)	(259,421)
Loss Before Income Taxes	(1,340,120)	(847,168)
Provision for income taxes
Net Loss	$ (1,340,120)	$ (847,168)
Basic net loss per share	$ (0.03)	$ (0.05)
Basic weighted average shares outstanding	42,634,127	15,504,818
Diluted net loss per share	$ (0.03)	$ (0.05)
Diluted weighted average shares outstanding	42,634,127	15,504,818

XML

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Statement of Cash Flows [Abstract]
Net Cash Used in Operating Activities	$ (138,825)	$ (144,527)
Net Cash Used in Investing Activities
Cash Flows Provided by Financing Activities:
Issuance of convertible promissory notes	265,200	90,000
Issuance of common stock under equity purchase agreements		42,944
Issuance of promissory note		25,000
Issuance of promissory notes to related parties		4,740
Repayment of promissory notes and accrued interest to related parties	(65,434)	(9,765)
Repayment of mortgage loan	(15,000)	(15,000)
Net Cash Provided by Financing Activities	184,766	137,919
Net Increase (Decrease) in Cash	45,941	(6,608)
Cash, beginning of period	2,555	9,163
Cash, end of period	48,496	2,555
Supplemental Disclosure of Cash Flow Information:
Cash paid during the year for interest	161,069	26,566
Supplemental Disclosure of Non-cash Financing Activities:
Conversion of convertible promissory notes	$ 714,942	$ 56,372

XML

The Company and Basis of Presentation

3 Months Ended

Mar. 31, 2018

The Company and Basis of Presentation [Abstract]

THE COMPANY AND BASIS OF PRESENTATION

1. THE COMPANY AND BASIS OF PRESENTATION

Nature of Organization

Coates International, Ltd. (the “Company” or “CIL”) has acquired the exclusive licensing rights to the patented Coates spherical rotary valve (“CSRV^®”) system technology in North America, Central America and South America (the “CSRV^® License”). The CSRV^® system technology has been developed over a period of more than 20 years by the Company’s founder George J. Coates, President and Chief Executive Officer, and his son Gregory G. Coates. The CSRV^® system technology is adaptable for use in piston-driven internal combustion engines of many types and has been patented in the United States and numerous countries throughout the world. The Company is endeavoring to raise working capital to commence production of hydrogen gas and natural gas powered CSRV^® industrial electric power generator sets (“Gen Sets)” and is also seeking to enter into sublicense agreements with third party, original equipment manufacturers (“OEM’s”) which provide for licensing fees. The Company is also continuing with research and development of a hydrogen reactor to harvest Hydroxy-Gas from water with the intent to power the Company’s products, including large industrial Gen Sets. George J. Coates, owner of the hydrogen reactor technology, has committed to license this technology to the Company once the related patent protection is in place.

Management believes that the CSRV^® engines provide the following advantages as compared to conventional internal combustion engines designed with “poppet valves”:

● Improved fuel efficiency

● Lower levels of harmful emissions

● Adaptability to numerous types of engine fuels

● Longer engine life

● Longer intervals between engine servicing

The CSRV^® system technology is designed to replace the intake and exhaust conventional “poppet valves” currently used in almost all piston-driven, automotive, truck, motorcycle, marine and electric power generator engines, among others. Unlike conventional valves which protrude into the engine combustion chamber, the CSRV^® system technology utilizes spherical valves that rotate in a cavity formed between a two-piece cylinder head. The CSRV^® system technology utilizes significantly fewer moving parts than conventional poppet valve assemblies. As a result of these design improvements, management believes that engines incorporating the CSRV^® system technology (“CSRV^® Engines”) will last significantly longer and will require less lubrication over the life of the engine, as compared to conventional engines. In addition, CSRV^® Engines can be designed with larger openings into the engine cylinder than with conventional valves so that more fuel and air can be inducted into, and expelled from the cylinder in a shorter period of time. Larger valve openings permit higher revolutions-per-minute (RPM’s) and permit higher compression ratios with lower combustion chamber temperatures, allowing the Coates Engine^® to produce more power than equivalent conventional engines. The extent to which CSRV^® Engines operating with the CSRV^® system technology achieve (i) higher RPM’s, (ii) greater volumetric efficiency and (iii) thermal efficiency than conventional engines, is a function of the engine design and application.

Basis of Presentation

The accompanying condensed financial statements include the accounts of the Company. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed financial statements have been reclassified to conform to the current period’s presentation.

These condensed financial statements and accompanying notes should be read in conjunction with the Company’s annual financial statements and the notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2017 and the Company’s quarterly financial statements and the notes thereto included in its Quarterly Reports.

Since the Company’s inception, the Company has been responsible for the development costs of the CSRV^® technology in order to optimize the value of the licensing rights and has incurred related operational costs, the bulk of which have been funded primarily through cash generated from licensing fees, sales of stock, short term convertible promissory notes, capital contributions, loans made by George J. Coates, Bernadette Coates, his spouse, Gregory G. Coates and certain directors, fees received from research and development of prototype models and a small number of CSRV^® engine generator sales. The Company has incurred substantial cumulative losses from operations since its inception. Losses from operations are expected to continue until the CSRV^® Engines^® are successfully introduced into the marketplace enabling the Company to generate substantial sales and/or receive substantial licensing revenues. These losses from operations were primarily related to research and development of the Company’s intellectual property rights, patent filing and maintenance costs and general and administrative expenses. The Company has also reported substantial non-cash expenses for stock-based compensation, remeasurement of the estimated fair value of embedded derivative liabilities related to convertible promissory notes issued and interest expense and losses on conversion of convertible promissory notes.

As shown in the accompanying financial statements, the Company has incurred recurring losses from operations and, as of March 31, 2018, had a stockholders’ deficiency of ($6,376,000). In addition, our mortgage loan which had a principal balance of $1,258,000 at March 31, 2018, matures in July 2018. The Company will be required to renegotiate the terms of an extension of the mortgage loan or successfully refinance the property with another mortgage lender, if possible. Failure to do so could adversely affect the Company’s financial position and results of operations. In addition, the recent trading price range of the Company’s common stock has introduced additional difficulty to the Company’s challenge to secure needed additional working capital. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has instituted a cost control program intended to restrict variable costs to only those expenses that are necessary to complete its activities related to entering the production phase of operations, develop additional commercially feasible applications of the CSRV^®system technology, seek additional sources of working capital and cover general and administrative costs in support of such activities. The Company has been actively undertaking efforts to secure new sources of working capital. At March 31, 2018, the Company had negative working capital of ($7,786,000) compared with negative working capital of ($7,467,000) at the end of 2017.

The Company continues to actively seek out new sources of working capital; however, there can be no assurance that it will be successful in these efforts. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Reverse Stock Split

The Company effected a one-for-200 reverse stock split of all of its outstanding shares of common stock, Series A Preferred Stock, Series B Convertible Preferred Stock, common stock warrants and stock options as of the close of trading on December 1, 2017. All prior year balances of shares of capital stock, warrants and stock options outstanding and all presentations and disclosures of transactions in shares of capital stock, warrants and stock options have been restated on a pro forma basis as if the reverse stock split had occurred prior to January 1, 2017. Such restatements include calculations regarding the Company’s weighted average shares outstanding and loss per share.

Inventory

Inventory consists of raw materials and work-in-process, including overhead. Inventory is stated at the lower of cost or net realizable value. Inventory is accounted for on the first-in, first-out method.

Use of Estimates

The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These significant estimates include determining the fair value of convertible promissory notes containing embedded derivatives and variable conversion rates, determining a value for shares of Series A Preferred Stock and Series B Convertible Preferred Stock issued, assigning useful lives to the Company’s property, plant and equipment, determining an appropriate amount to reserve for obsolete and slow moving inventory, estimating a valuation allowance for deferred tax assets, assigning expected lives to, and estimating the rate of forfeitures of, stock options granted and selecting a trading price volatility factor for the Company’s common stock in order to estimate the fair value of the Company’s stock options on the date of grant or other appropriate measurement date. Actual results could differ from those estimates.

XML

Concentrations of Credit and Business Risk

3 Months Ended

Mar. 31, 2018

Concentrations of Credit and Business Risk [Abstract]

CONCENTRATIONS OF CREDIT AND BUSINESS RISK

2. CONCENTRATIONS OF CREDIT AND BUSINESS RISK

The Company maintains cash balances with one financial institution. Monies on deposit are fully insured by the Federal Deposit Insurance Corporation.

The Company’s operations are devoted to the development, application, licensing and marketing of the CSRV^® system technology which was invented by George J. Coates, the Company’s founder, Chairman, Chief Executive Officer, President and controlling stockholder. Development efforts have been conducted continuously during this time. From July 1982 through May 1993, seven U.S. patents as well as a number of foreign patents were issued with respect to the CSRV^® system technology. Since inception of the Company in 1988, all aspects of the business have been completely dependent upon the activities of George J. Coates. The loss of George J. Coates’ availability or service due to death, incapacity or otherwise would have a material adverse effect on the Company's business and operations. The Company does not presently have any key-man life insurance in force for Mr. Coates.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2018

Fair Value of Financial Instruments [Abstract]

FAIR VALUE OF FINANCIAL INSTRUMENTS

3. FAIR VALUE OF FINANCIAL INSTRUMENTS

Cash, Other Assets, Accounts Payable and Accrued Liabilities and Other Liabilities

With the exception of convertible promissory notes, the carrying amount of these items approximates their fair value because of the short term maturity of these instruments. The convertible promissory notes are reported at their estimated fair value, determined as described in more detail in Note 15.

Limitations

Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

XML

Licensing Agreement and Deferred Licensing Costs

3 Months Ended

Mar. 31, 2018

Licensing Agreement and Deferred Licensing Costs [Abstract]

LICENSING AGREEMENT AND DEFERRED LICENSING COSTS

4. LICENSING AGREEMENT AND DEFERRED LICENSING COSTS

The Company holds a manufacturing, use, lease and sale license from George J. Coates and Gregory G. Coates for the CSRV^® system technology in the territory defined as the Western Hemisphere (the “License Agreement”). Under the License Agreement, George J. Coates and Gregory G. Coates granted to the Company an exclusive, perpetual, royalty-free, fully paid-up license to the patented intellectual property that specifically relates to an internal combustion engine that incorporates the CSRV^® system technology (the “CSRV^® Engine”) and that is currently owned or controlled by them (the “CSRV^® Intellectual Property”), plus any CSRV^® Intellectual Property that is developed by them during their employment with the Company. In the event of insolvency or bankruptcy of the Company, the licensed rights would terminate and ownership would revert back to George J. Coates and Gregory G. Coates.

Under the License Agreement, George J. Coates and Gregory G. Coates agreed that they will not grant any Western Hemisphere licenses to any other party with respect to the CSRV^® Intellectual Property.

At March 31, 2018 and December 31, 2017, deferred licensing costs, comprised of expenditures for patent costs incurred pursuant to the CSRV^® licensing agreement, net of accumulated amortization, amounted to $33,000 and $34,000, respectively. Amortization expense for the three months ended March 31, 2018 and 2017 amounted to $1,000 and $1,000, respectively.

XML

Agreement Assigned to Almont Energy, Inc.

3 Months Ended

Mar. 31, 2018

Agreement Assigned to Almont Energy, Inc. [Abstract]

AGREEMENT ASSIGNED TO ALMONT ENERGY, INC.

5. AGREEMENT ASSIGNED TO ALMONT ENERGY, INC.

In 2010, Almont Energy Inc. (“Almont”), a privately held, independent third-party entity based in Alberta, Canada became the assignee of a sublicense which covers the use of the CSRV^® system technology in the territory of Canada in the oil and gas industry (the “Canadian License”). This sublicense is currently inactive because the parties have not fulfilled their obligations thereunder due to the Company’s delay in starting up production and delivery of CSRV^® products to Almont. The parties mutually agreed to consider the basis on which the license could be reactivated at such time that the Company is successful in starting up its manufacturing operations.

In prior years, the Company received a non-refundable $300,000 deposit on the Canadian License. As the Company continues to be desirous of commencing shipments of its CSRV® products to Almont under the sublicense at such time that it is able to start up production operations, it has continued to amortize this deposit into income over the period until expiration of the last CSRV^® system technology patent in force. At March 31, 2018, amortization of the unamortized balance is as follows:

Year Ending	Amount
2018		14,000
2019		19,000
2020		19,000
2021		19,000
Thereafter		94,000
	$	165,000

At March 31, 2018 and December 31, 2017, the unamortized balance of this license deposit was $165,000 and $170,000, respectively. The current portion of $19,000 is included in sublicense deposits under current assets and the remainder of the balance is included in non-current sublicense deposits on the accompanying balance sheets at March 31, 2018 and December 31, 2017, respectively.

XML

Non-Exclusive Distribution Sublicense with Renown Power Development, Ltd.

3 Months Ended

Mar. 31, 2018

Non-Exclusive Distribution Sublicense with Renown Power Development, Ltd. [Abstract]

NON-EXCLUSIVE DISTRIBUTION SUBLICENSE WITH RENOWN POWER DEVELOPMENT, LTD.

6. NON-EXCLUSIVE DISTRIBUTION SUBLICENSE WITH RENOWN POWER DEVELOPMENT, LTD.

In February 2015, the Company granted a non-exclusive distribution sublicense to Renown Power Development, Ltd., a China-based sales and distribution company (“Renown”) covering the territory defined as the Western Hemisphere. Under this sublicense, Renown will be permitted to sell, lease and distribute CSRV^® products. Renown intends to source CSRV^® products from Coates Power, Ltd., a China-based company formed for the purpose of manufacturing CSRV^® products (“Coates Power”). Coates Power has not been able to commence operations due to ongoing delays in obtaining necessary support and approval from the Chinese government in spite of continuing efforts by Renown to do so on its behalf. This has been and continues to be a long, arduous process because the government is addressing this at a very slow pace. As of March 31, 2018, the Company has only received an initial non-refundable deposit of $500,000. Until Coates Power can begin production of CSRV^® products for Renown, the Company will not receive any further monies from its sublicense with Renown.

At this time, as the Company’s intellectual property rights only cover the territory of North America, it does not have any rights to enter into a manufacturing and sale license agreement with Coates Power. These rights are currently held by George J. Coates, Gregory G. Coates and The Coates Trust, a trust controlled by George J. Coates. Coates Power and Renown are controlled and managed by Mr. James Pang, the Company’s liaison agent in China.

The Company received a $131,000 cash deposit with an order from Coates Power to produce two Gen Sets. This amount is included in Deposits in the accompanying balance sheets at March 31, 2018 and December 31, 2017. The Company intends to build and ship these two generators at such time that Coates Power is able to commence production in accordance with the manufacturing license agreement and there is sufficient working capital for this purpose.

XML

Other Current Assets

3 Months Ended

Mar. 31, 2018

Other Current Assets [Abstract]

OTHER CURRENT ASSETS

7. OTHER CURRENT ASSETS

Other current assets at March 31, 2018 and December 31, 2017 amounted to $50,000 and $1,000, respectively. The balance at March 31, 2018 included $48,000 for inventory billed, but not received.

XML

Inventory

3 Months Ended

Mar. 31, 2018

Inventory [Abstract]

INVENTORY

8. INVENTORY

Inventory consisted of the following:

	March 31, 2018		December 31, 2017
Raw materials	$	102,000	$	104,000

XML

License Deposits

3 Months Ended

Mar. 31, 2018

License Deposits [Abstract]

LICENSE DEPOSITS

9. LICENSE DEPOSITS

Sublicensing fee revenue for the three months ended March 31, 2018 and 2017 amounted to $5,000 and $5,000, respectively.

XML

Property, Plant and Equipment

3 Months Ended

Mar. 31, 2018

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT

10. PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment at cost, less accumulated depreciation, consists of the following:

	March 31, 2018			December 31,  2016
Land	$	1,235,000		$	1,235,000
Building		964,000			964,000
Building improvements		83,000			83,000
Machinery and equipment		689,000			689,000
Furniture and fixtures		57,000			57,000
		3,028,000			3.028,000
Less:  Accumulated depreciation		(1,006,000	)		(996,000	)
Total	$	2,022,000		$	2,032,000

Depreciation expense amounted to $10,000 and $11,000 for the three months ended March 31, 2018 and 2017, respectively.

XML

Mortgage Loan Payable

3 Months Ended

Mar. 31, 2018

Mortgage Loan Payable/Promissory Notes [Abstract]

MORTGAGE LOAN PAYABLE

11. MORTGAGE LOAN PAYABLE

The Company has a mortgage loan on the land and building that serves as its headquarters and research and development facility which bears interest at the rate of 7.5% per annum and matures in July 2018. Interest expense for the three months ended March 31, 2018 and 2017 amounted to $24,000 and $25,000, respectively. The loan requires monthly payments of interest, plus $5,000 which is being applied to the principal balance. The remaining principal balance at March 31, 2018 and December 31, 2017 was $1,258,000 and $1,273,000, respectively. The mortgage loan may be prepaid in whole, or, in part, at any time without penalty. The Company will be required to renegotiate the terms of a further extension of the mortgage loan or successfully refinance the property with another mortgage lender, if possible. Failure to do so, could adversely affect the Company’s financial position and results of operations.

The loan is collateralized by a security interest in all of the Company’s assets, the pledge of 25,000 shares of common stock of the Company owned by George J. Coates, which were deposited into escrow for the benefit of the lender and the personal guarantee of George J. Coates. The Company is not permitted to create or permit any secondary mortgage or similar liens on the property or improvements thereon without prior consent of the lender.

XML

Accounts Payable and Accrued Liabilities

3 Months Ended

Mar. 31, 2018

Accounts Payable and Accrued Liabilities [Abstract]

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

12. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities are as follows:

	March 31, 2018		December 31, 2017
Legal and professional fees	$	1,396,000	$	1,427,000
Accrued interest expense		622,000		582,000
General and administrative expenses		528,000		420,000
Research and development costs		115,000		115,000
Total	$	2,661,000	$	2,544,000

XML

Promissory Notes to Related Parties

3 Months Ended

Mar. 31, 2018

Promissory Notes to Related Parties [Abstract]

PROMISSORY NOTES TO RELATED PARTIES

13. PROMISSORY NOTES TO RELATED PARTIES

Promissory Notes Issued to George J. Coates

During the three months ended March 31, 2018 and 2017, the Company issued, in a series of transactions, promissory notes to George J. Coates and received cash proceeds of $-0- and $4,000, respectively and repaid promissory notes to George J. Coates in the aggregate principal amount of $20,000 and $4,000, respectively. Interest expense for the three months ended March 31, 2018 and 2017 amounted to $13,000 and $13,000, respectively.

The promissory notes are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly. At March 31, 2018, the outstanding principal balance was $-0- and the balance of unpaid accrued interest was $331,000.

Promissory Note Issued to Gregory G. Coates

The Company has a non-interest bearing promissory note due to Gregory G. Coates which is payable on demand. Interest is being imputed on this promissory note at the rate of 10% per annum. During the three months ended March 31, 2018 and 2017, the Company, partially repaid $15,000 and $-0-, respectively of this promissory note. Imputed interest expense for the three months ended March 31, 2018 and 2017, amounted to $35,000 and $35,000, respectively. At March 31, 2018, the outstanding principal balance was $1,403,000.

Promissory Notes Issued to Bernadette Coates

During the three months ended March 31, 2018 and 2017, the Company issued promissory notes to Bernadette Coates, spouse of George J. Coates and received cash proceeds of $-0- and $1,000, respectively. The Company repaid promissory notes to Bernadette Coates in the principal amount of $15,000 and $6,000, respectively. The promissory notes are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly. Interest expense for the three months ended March 31, 2018 and 2017, amounted to $7,000 and $3,000, respectively. At March 31, 2018, the outstanding principal balance was $14,000.

Promissory Note Issued to Employee

The Company issued a promissory note to an employee which was payable on demand and provided for interest at the rate of 17% per annum, compounded monthly. In February 2018, this note was repaid in full along with accrued interest thereon of $1,400.

The aggregate amount of unpaid accrued interest on all promissory notes amounting to $432,000 is included in accounts payable and accrued liabilities in the accompanying balance sheet at March 31, 2018.

XML

Promissory Note

3 Months Ended

Mar. 31, 2018

Mortgage Loan Payable/Promissory Notes [Abstract]

PROMISSORY NOTE

14. PROMISSORY NOTE

In March 2017, the Company issued a $25,000 promissory note with a maturity date of May 13, 2017. Interest was payable upon maturity in the form of 10,000,000 shares of unregistered, restricted shares of the Company's common stock. In addition, the Company agreed to extend warrants held by the lender to purchase 10,839,752 shares of common stock that were scheduled to expire in 2017 for an additional five years and modify the exercise price to $0.03 per share. On May 5, 2017, the Company prepaid the note in full and issued 8,688,525 shares of its common stock representing the prorated number of shares for interest on the note, as a result of the prepayment. Interest expense of $4,000 was recorded for issuance of these shares based on the closing trading price on the date of issuance.

XML

Convertible Promissory Notes and Embedded Derivative Liability

3 Months Ended

Mar. 31, 2018

Convertible Promissory Notes and Embedded Derivative Liability [Abstract]

CONVERTIBLE PROMISSORY NOTES AND EMBEDDED DERIVATIVE LIABILITY

15. CONVERTIBLE PROMISSORY NOTES AND EMBEDDED DERIVATIVE LIABILITY

From time to time, the Company issues convertible promissory notes, the proceeds of which are used for general working capital purposes. At March 31, 2018, there was $385,000 principal amount of convertible promissory notes outstanding. During the three months ended March 31, 2018 and 2017, $287,000 and $93,000 of convertible promissory notes were issued, respectively. Outstanding notes may be converted into unregistered shares of the Company’s common stock at a discount ranging from 30% to 39% of the defined trading price of the common stock on the date of conversion. The defined trading prices are based on the trading price of the stock during a defined period ranging from ten to twenty-five trading days immediately preceding the date of conversion. The conversion rate discount establishes a beneficial conversion feature (“BCF”) or unamortized discount, which is required to be valued and accreted to interest expense over the six-month period until the conversion of the notes into restricted shares of common stock is permitted. In addition, the conversion formula meets the conditions that require accounting for convertible notes as derivative liability instruments. The effective interest rate on the outstanding convertible notes at March 31, 2018 ranged from 107% to 147%. The unamortized discount on the outstanding convertible notes at March 31, 2018 and December 31, 2017 amounted to $116,000 and $52,000, respectively.

The convertible notes generally become convertible, in whole, or in part, beginning on the six month anniversary of the issuance date and may be prepaid at the option of the Company, with a prepayment penalty ranging from 15% to 50% of the principal amount of the convertible note at any time prior to becoming eligible for conversion.

One convertible promissory note with an aggregate outstanding balance of $53,000 is convertible in monthly installments in an amount determined by the noteholder, plus accrued interest. The Company may elect, at its option to repay each monthly installment in whole, or in part, in cash, without penalty. The amount of each installment not paid in cash is converted into shares of the Company’s common stock. This convertible note also requires that the conversion price be re-measured 23 trading days after the conversion shares are originally delivered. If the re-measured conversion price is lower, then the Company is required to issue additional conversion shares to the noteholder.

In accordance with GAAP, the estimated fair value of the embedded derivative liability related to the convertible notes is required to be remeasured at each balance sheet date. The fair value measurement accounting standard establishes a valuation hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used, when available. Observable inputs are inputs market participants would use in valuing the asset or liability developed based on independent market data sources. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available. The valuation hierarchy is composed of three categories, which are as follows:

● Level 1 – Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.

● Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly.

● Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques.

The estimated fair value of the embedded derivative liabilities related to promissory notes outstanding was measured as the aggregate estimated fair value, based on Level 2 inputs, which included quoted daily yield curve rates of treasury securities with comparable maturities and, because the actual volatility rate on the Company’s common stock is not available, a conservative estimated volatility rate of 200%.

The embedded derivative liability arises because, based on historical trading patterns of the Company’s stock, the formula for determining the Conversion Rate is expected to result in a different Conversion Rate than the closing price of the stock on the actual date of conversion (hereinafter referred to as the “Variable Conversion Rate Differential”). The estimated fair values of the derivative liabilities have been calculated based on a Black-Scholes option pricing model.

The following table presents the Company's fair value hierarchy of financial assets and liabilities measured at fair value at:

	March 31, 2018		December 31, 2017
Level 1 Inputs	$	-	$	-
Level 2 Inputs		497,000		359,000
Level 3 Inputs		-		-
Total	$	497,000	$	359,000

In a series of transactions, during the three months ended March 31, 2018, convertible promissory notes with an aggregate principal balance of $82,000, including accrued interest thereon were converted into 8,357,452 unregistered shares of common stock. The Company incurred a loss on these conversions amounting to $21,000 for the three months ended March 31, 2018.

In a series of transactions, during the three months ended March 31, 2017, convertible promissory notes with an aggregate principal balance of $56,000, including accrued interest thereon were converted into 854,365 unregistered shares of common stock. The Company incurred a loss on these conversions amounting to $12,000 for the three months ended March 31, 2017.

At March 31, 2018, the Company did not have enough unissued, authorized shares of its common stock to meet the 160,748,286-share aggregate contractual reserve requirements of its outstanding convertible debt. This was due to the filing of a Certificate of Validation with the Secretary of State of Delaware on April 2, 2018, as more fully discussed in Note 24, which reduced the number of authorized shares of common stock from 12,000,000,000 to 120,000,000. This reduction was retroactive to the close of trading in the Company's common stock on December 1, 2017. The Company has obtained 90-day waivers of this default from each of the convertible noteholders. As discussed in more detail in Note 24, on May 7, 2018, the Company filed a Notice of Conversion with the Secretary of State of Nevada, which increased the number of authorized shares of the Company's common stock from 120,000,000 to 2,400,000,000, thereby automatically curing this default condition for all convertible notes. At March 31, 2018, $149,000 of the Company’s outstanding convertible notes were eligible for conversion.

The Company made the private placement of these securities in reliance upon Section 4(2) of the Securities Act of 1933, as amended (the “Act”), Rule 506 of Regulation D, and the rules and regulations promulgated thereunder, and/or upon any other exemption from the registration requirements of the Act, as applicable.

XML

Capital Stock

3 Months Ended

Mar. 31, 2018

Capital Stock/Stock Options [Abstract]

CAPITAL STOCK

16. CAPITAL STOCK

Common Stock

The Company’s common stock is traded on OTC Pink Sheets. Investors can find real-time quotes and market information for the Company at www.otcmarkets.com market system under the ticker symbol COTE. The Company is authorized to issue up to 120,000,000 shares of common stock, par value, $0.0001 per share (the “Common Stock”).

At the close of trading in the Company’s common stock on December 1, 2017, a 1:200 reverse stock split of all of the Company’s shares of common stock, shares of preferred stock, common stock warrants and stock options became effective. Shareholders were paid cash-in-lieu of any fractional shares that would have resulted in connection with the reverse stock split. The reverse stock split was approved by the board of directors and George J. Coates, the majority stockholder by means of a written consent. For purposes of presenting the accompanying financial statements as of March 31, 2018 and December 31, 2017 and for the three months ended March 31, 2018, all balances, transactions and calculations were restated on a pro forma basis as if the reverse stock split occurred prior to the beginning of the year ended December 31, 2017.

The following common stock transactions occurred during the three months ended March 31, 2018:

● In a series of transactions, convertible promissory notes with an aggregate principal balance of $82,000, including accrued interest thereon were converted into 8,375,452 unregistered shares of common stock.

The following common stock transactions occurred during the nine months ended September 30, 2017:

● In a series of transactions during the three months ended March 31, 2017, convertible promissory notes with an aggregate principal balance of $56,000, including accrued interest thereon were converted into 854,365 unregistered shares of common stock.

● During the three months ended March 31, 2017, Barry C. Kaye converted 6.86 shares of Series B into 6,860 unregistered, restricted shares of the Company’s common stock.

Preferred Stock and anti-dilution rights

The Company is authorized to issue 350,000 shares of preferred stock, par value, $0.001 per share (the “Preferred Stock”). The Company may issue any class of the Preferred Stock in any series. The board is authorized to establish and designate series, and to fix the number of shares included in each such series and the relative rights, preferences and limitations as between series, provided that, if the stated dividends and amounts payable on liquidation are not paid in full, the shares of all series of the same class shall share ratably in the payment of dividends including accumulations, if any, in accordance with the sums which would be payable on such shares if all dividends were declared and paid in full and in any distribution of assets other than by way of dividends in accordance with the sums which would be payable on such distribution if all sums payable were discharged in full. Shares of each such series when issued, shall be designated to distinguish the shares of each series from shares of all other series.

There are two series of Preferred Stock that have been designated to date from the total 100,000,000 authorized shares of Preferred Stock. These are as follows:

● Series A Preferred Stock, par value $0.001 per share (“Series A”), 5,000 shares designated, 3,601 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively. Shares of Series A entitle the holder to 10,000 votes per share on all matters brought before the shareholders for a vote. These shares are not entitled to receive dividends or share in distributions of capital and have no liquidation preference. All outstanding shares of Series A are owned by George J. Coates, which entitle him to 36,010,000 million votes in addition to his voting rights from the shares of common stock and the shares of Series B he holds.

The Company may issue additional shares of Series A Preferred Stock to Mr. Coates if deemed necessary to provide anti-dilution protection and maintain his ownership percentage of eligible votes.

Issuances of shares of Series A to George J. Coates do not have any effect on the share of dividends or liquidation value of the holders of the Company’s common stock. However, the voting rights of the holders of the Company’s common stock are diluted with each issuance.

During the three months ended March 31, 2017, the Company issued 3,351 shares of Series A Preferred Stock to George J. Coates representing anti-dilution shares to restore Mr. Coates’ percentage of eligible votes to 85.7%. This percentage increased as a result of Mr. Coates’ acquisition of additional shares of common stock in 2016.

● Series B Convertible Preferred Stock, par value $0.001 per share, 345,000 shares designated and 281,378 and 228,471 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively. Shares of Series B do not earn any dividends and may be converted at the option of the holder at any time beginning on the second annual anniversary date after the date of issuance into 1,000 unregistered shares of the Company’s common stock. Holders of the Series B are entitled to one thousand votes per share held on all matters brought before the shareholders for a vote.

In the event that either (i) the Company enters into an underwriting agreement for a secondary public offering of securities, or (ii) a change in control of the Company is consummated representing 50% more of the then outstanding shares of Company’s common stock, plus the number of shares of common stock into which any convertible preferred stock is convertible, regardless of whether or not such shares are otherwise eligible for conversion, then the Series B may be immediately converted at the option of the holder into restricted shares of the Company’s common stock. 

The Company provides anti-dilution protection for certain of its key employees. For each new share of common stock issued by the Company to non-Coates family members in the future, additional shares of Series B will be issued to maintain their fixed ownership percentage of the Company. The fixed ownership percentage is adjusted for acquisitions and dispositions of common stock, not related to conversions of Series B Convertible Preferred Stock, by these key employees. At March 31, 2018, the fixed ownership percentages were as follows:

1. George J. Coates – 80.63%

2. Gregory G. Coates – 6.10%

3. Barry C. Kaye – 0.048%

These anti-dilution provisions do not apply to new shares of common stock issued in connection with exercises of employee stock options, a secondary public offering of the Company’s securities or a merger or acquisition.

The following presents by year, the number of shares of Series B held and the year that they become eligible for conversion into shares of common stock, as of March 31, 2018.

	Total		2018		2019		2020
George J. Coates		260,020		74,506		136,599		48,915
Gregory G. Coates		19,832		5,484		10,646		3,702
Barry C. Kaye		1,526		413		823		290
Total		281,378		80,403		148,068		52,907

For the three months ended March 31, 2018, 48,915, 3,702 and 290 shares of Series B were issued to George J. Coates, Gregory G. Coates and Barry C. Kaye, respectively, having an estimated fair value of $545,000, $41,000 and $3,000, respectively. These amounts were included in stock-based compensation expense in the accompanying statement of operations for the three months ended March 31, 2018.

For the three months ended March 31, 2017, 3,861, 597 and 47 shares of Series B were issued to George J. Coates, Gregory G. Coates and Barry C. Kaye, respectively, having an estimated fair value of $132,000, $39,000 and $3,000, respectively. These amounts were included in stock-based compensation expense in the accompanying statement of operations for the nine months ended March 31, 2017.

During the three months ended March 31, 2017, Barry C. Kaye converted 6.86 shares of Series B into 6,868 unregistered, restricted shares of the Company’s common stock.

In the event that all of the 281,378 shares of Series B outstanding at March 31, 2018 were converted, once the conversion restrictions lapse, an additional 281,378,000 new restricted shares of common stock would be issued. On a pro forma basis, based on the number of shares of common stock outstanding at March 31, 2018, this would dilute the ownership percentage of non-affiliated stockholders from 85.4% to 12.8%.

To the extent that additional shares of Series B are issued under the anti-dilution plan, the non-affiliated stockholders’ percentage ownership of the Company would be further diluted.

XML

Loss Per Share

3 Months Ended

Mar. 31, 2018

Loss Per Share [Abstract]

LOSS PER SHARE

17. LOSS PER SHARE

At March 31, 2018, there were stock warrants outstanding to purchase 741,725 shares of common stock at exercise prices ranging from $0.10 to $13.50 per share, vested stock options outstanding to acquire 62,350 shares of common stock at exercise prices ranging from $5.60 to $88.00 per share and $385,000 of convertible promissory notes outstanding, which on a pro forma basis assuming all such promissory notes were converted into shares of common stock using the contractual conversion price determined as of the close of trading on the last trading in March 2018, would have been convertible into 33,314,645 shares of common stock.

At March 31, 2017, there were stock warrants outstanding to purchase 751,725 shares of common stock at exercise prices ranging from $0.10 to $13.50 per share, vested stock options outstanding to acquire 62,350 shares of common stock at exercise prices ranging from $5.60 to $88.00 per share and $140,000 of convertible promissory notes outstanding, which on a pro forma basis assuming all such promissory notes were converted into shares of common stock using the contractual conversion price determined as of the close of trading on the last trading in March 2017, would have been convertible into 3,257,093 shares of common stock.

For the three months ended March 31, 2018 and 2017, none of the potentially issuable shares of common stock were assumed to be converted because the Company incurred a net loss in those periods and the effect of including them in the calculation of earnings per share would have been anti-dilutive.

XML

Stock Options

3 Months Ended

Mar. 31, 2018

Capital Stock/Stock Options [Abstract]

STOCK OPTIONS

18. STOCK OPTIONS

The Company’s 2006 Stock Option and Incentive Plan (the “Stock Plan”) was adopted by the Company’s board in October 2006. In September 2007, the Stock Plan, by consent of George J. Coates, majority shareholder, was adopted by our shareholders. The Stock Plan provides for the grant of stock-based awards to employees, officers and directors of, and consultants or advisors to, the Company and its subsidiaries, if any. Under the Stock Plan, the Company may grant options that are intended to qualify as incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (“ISO’s”), options not intended to qualify as incentive stock options (“non-statutory options”), restricted stock and other stock-based awards. ISO’s may be granted only to employees of the Company. All of the shares of common stock authorized under the Stock Plan have been granted and no further grants may be awarded thereunder.

The Company established a 2014 Stock Option and Incentive Plan (the “2014 Stock Plan”) which was adopted by the Company’s board on May 30, 2014. On March 2, 2015, the 2014 Stock Plan, by consent of George J. Coates, majority shareholder, was adopted by our shareholders. The 2014 Stock Plan provides for the grant of stock-based awards to employees, officers and directors of, and consultants or advisors to, the Company and its subsidiaries, if any. Under the 2014 Stock Plan, the Company may grant ISO’s, non-statutory options, restricted stock and other stock-based awards. ISO’s may be granted only to employees of the Company. A total of 50,000,000 shares of common stock may be issued upon the exercise of options or other awards granted under the 2014 Stock Plan. The maximum number of shares with respect to which awards may be granted during any one year to any employee under the 2014 Stock Plan shall not exceed 25% of the 50,000,000 shares of common stock covered by the 2014 Stock Plan. At June 30, 2017, none of the shares of common stock authorized under the 2014 Stock Plan had been granted as stock options or awards.

The Stock Plan and the 2014 Stock Plan (the “Stock Plans”) are administered by the board and the Compensation Committee. Subject to the provisions of the Stock Plans, the board and the Compensation Committee each has the authority to select the persons to whom awards are granted and determine the terms of each award, including the number of shares of common stock subject to the award. Payment of the exercise price of an award may be made in cash, in a “cashless exercise” through a broker, or if the applicable stock option agreement permits, shares of common stock, or by any other method approved by the board or Compensation Committee. Unless otherwise permitted by the Company, awards are not assignable or transferable except by will or the laws of descent and distribution.

Upon the consummation of an acquisition of the business of the Company, by merger or otherwise, the board shall, as to outstanding awards (on the same basis or on different bases as the board shall specify), make appropriate provision for the continuation of such awards by the Company or the assumption of such awards by the surviving or acquiring entity and by substituting on an equitable basis for the shares then subject to such awards either (a) the consideration payable with respect to the outstanding shares of common stock in connection with the acquisition, (b) shares of stock of the surviving or acquiring corporation, or (c) such other securities or other consideration as the board deems appropriate, the fair market value of which (as determined by the board in its sole discretion) shall not materially differ from the fair market value of the shares of common stock subject to such awards immediately preceding the acquisition. In addition to, or in lieu of the foregoing, with respect to outstanding stock options, the board may, on the same basis or on different bases as the board shall specify, upon written notice to the affected optionees, provide that one or more options then outstanding must be exercised, in whole or in part, within a specified number of days of the date of such notice, at the end of which period such options shall terminate, or provide that one or more options then outstanding, in whole or in part, shall be terminated in exchange for a cash payment equal to the excess of the fair market value (as determined by the board in its sole discretion) for the shares subject to such stock options over the exercise price thereof. Unless otherwise determined by the board (on the same basis or on different bases as the board shall specify), any repurchase rights or other rights of the Company that relate to a stock option or other award shall continue to apply to consideration, including cash, that has been substituted, assumed or amended for a stock option or other award pursuant to these provisions. The Company may hold in escrow all or any portion of any such consideration in order to effectuate any continuing restrictions.

The board may at any time provide that any stock options shall become immediately exercisable in full or in part, that any restricted stock awards shall be free of some or all restrictions, or that any other stock-based awards may become exercisable in full or in part or free of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be.

The board or Compensation Committee may, in its sole discretion, amend, modify or terminate any award granted or made under the Stock Plan, so long as such amendment, modification or termination would not materially and adversely affect the participant.

During the three months ended March 31, 2018 and 2017, no stock options were granted. There were no unvested stock options outstanding at March 31, 2018.

During the three months ended March 31, 2018 and 2017, the Company did not incur any stock-based compensation expense related to employee stock options. At March 31, 2018, all stock-based compensation expense related to outstanding stock options had been fully recognized.

Details of the stock options outstanding under the Company’s Stock Option Plans are as follows:

	Exercise Price Per Share		Number Outstanding		Weighted Average Remaining Contractual Life		Number Exercisable		Weighted Average Exercise Price		Weighted Average Fair Value Per Stock Option at Date of Grant
Balance, 3/31/18	$	5.60 – $88.00		62,500		9		62,500	$	36.34	$	33.84

No stock options were exercised, forfeited or expired during the three months ended March 31, 2018 and 2017.

The weighted average fair value of the Company's stock options was estimated using the Black-Scholes option pricing model which requires highly subjective assumptions including the expected stock price volatility. These assumptions were as follows:

●	Historical stock price volatility	139% - 325%
●	Risk-free interest rate	0.21% - 4.64%
●	Expected life (in years)	4
●	Dividend yield	$0.00

The valuation assumptions were determined as follows:

● Historical stock price volatility: The Company utilized the volatility in the trading of its common stock computed for the 12 months of trading immediately preceding the date of grant.

● Risk-free interest rate: The Company bases the risk-free interest rate on the interest rate payable on U.S. Treasury securities in effect at the time of the grant for a period that is commensurate with the assumed expected option life.

● Expected life: The expected life of the options represents the period of time options are expected to be outstanding. The Company has very limited historical data on which to base this estimate. Accordingly, the Company estimated the expected life based on its assumption that the executives will be subject to frequent blackout periods during the time that the stock options will be exercisable and based on the Company’s expectation that it will complete its research and development phase and commence its initial production phase. The vesting period of these options was also considered in the determination of the expected life of each stock option grant.

● No expected dividends.

XML

Income Taxes

3 Months Ended

Mar. 31, 2018

Income Taxes [Abstract]

INCOME TAXES

19. INCOME TAXES

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

Deferred tax assets increased by $247,000 and $833,000 for the three months ended March 31, 2018 and 2017, respectively. These amounts were fully offset by a corresponding increase in the tax valuation allowance resulting in no net change in deferred tax assets, respectively, during these periods.

No liability for unrecognized tax benefits was required to be reported at March 31, 2018 and December 31, 2017.  Based on the Company's evaluation, it has concluded that there are no significant uncertain tax positions requiring recognition in the Company's financial statements. The Company's evaluation was performed for tax years ended 2014 through 2016, the only periods subject to examination. The Company believes that its income tax positions and deductions will be sustained on audit and does not anticipate that adjustments, if any, will result in a material change to its financial position. For the three months ended March 31, 2018 and 2017, there were no penalties or interest related to the Company’s income tax returns.

At March 31, 2018, the Company had available, $20,908,000 of net operating loss carryforwards which may be used to reduce future federal taxable income, expiring between 2018 and 2038 and $10,504,000 of net operating loss carryforwards which may be used to reduce future state taxable income, expiring between 2029 and 2038.

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2018

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

20. RELATED PARTY TRANSACTIONS

Licensing Agreement for CSRV^® System Technology

The Company’s intellectual property rights for the CSRV^® System Technology are derived from the licensing agreement with George J. Coates and Gregory G. Coates, as more fully discussed in Note 4. The Company pays for all costs of new patent filings and patent maintenance on intellectual properties licensed to it by George J. Coates and Gregory G. Coates. For the three months ended March 31, 2018 and 2017, these costs amounted to $4,000 and $4,000, respectively.

Non-Exclusive distribution sublicense to Renown Power Development, Ltd.

The Company has granted a non-exclusive distribution sublicense to Renown, as more fully discussed in Note 6. Renown is controlled by James Pang, the Company’s exclusive liaison agent in China.

Issuances of Promissory Notes to Related Parties

Issuances of promissory notes to related parties during the three months ended March 31, 2018 and 2017, are discussed in detail in Note 15.

Promissory notes issued to George J. Coates, Bernadette Coates and an employee are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly. The promissory note issued to Gregory G. Coates is non-interest bearing, however, the Company imputes interest at a rate of 10% per annum, which has been charged to interest expense in the accompanying statements of operations.

Stock Options

Stock options previously granted to related parties, all of which are fully vested are more fully discussed in Note 18.

Issuances and Conversions of Preferred Stock

Shares of Series A Preferred Stock awarded to George J. Coates during the three months ended March 31, 2018 and 2017 are discussed in detail in Note 16.

Shares of Series B Convertible Preferred Stock awarded to George J. Coates, Gregory G. Coates and Barry C. Kaye and shares converted during the three months ended March 31, 2018 and 2017, are discussed in detail in Note 16.

Personal Guaranty and Stock Pledge

In connection with the Company’s mortgage loan on the Company’s headquarters facility, George J. Coates has pledged certain of his shares of common stock of the Company to the extent required by the lender and provided a personal guaranty as additional collateral.

Compensation and Benefits Paid

The approximate amount of compensation and benefits, all of which were approved by the board, paid to George J. Coates, Gregory G. Coates and Bernadette Coates, exclusive of stock-based compensation for unregistered, restricted shares of Preferred Stock awarded to George J. Coates and Gregory G. Coates is summarized as follows:

	For the three months ended March 31,
	2018		2017
George J. Coates (a) (b)	$	4,000	$	14,000
Gregory G. Coates (c) (d)		24,000		3,000
Bernadette Coates (e)		-		-

(a) For the three months ended March 31, 2018 and 2017, George J. Coates earned additional base compensation of $63,000 and $53,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $1,283,000 and $1,221,000, respectively.

(b) During the three months ended March 31, 2018 and 2017, George J. Coates was awarded Series A Preferred Stock and Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

(c) For the three months ended March 31, 2018 and 2017, Gregory G. Coates earned additional base compensation of $19,000 and $38,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $161,000 and $143,000, respectively.

(d) During the three months ended March 31, 2018 and 2017, Gregory G. Coates was awarded Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

(e) The Company had been deferring base compensation for Bernadette Coates, who retired in 2016, until it has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $242,000.

During the three months ended March 31, 2018 and 2017, Barry C. Kaye, Treasurer and Chief Financial Officer was paid compensation of $35,000 and $10,000, respectively. For the three months ended March 31, 2018 and 2017, Mr. Kaye earned compensation of $33,000 and $32,000, respectively, which was not paid and is being deferred until the Company has sufficient working capital to remit payment to him. During the three months ended March 31, 2018 and 2017, interest accrued on Mr. Kaye’s deferred compensation amounted to $18,000 and $13,000, respectively. At March 31, 2018, the total amount of Mr. Kaye’s unpaid, deferred compensation, including accrued interest thereon, was $434,000. This amount is included in accounts payable and accrued liabilities in the accompanying balance sheet at March 31, 2018. During the three months ended March 31, 2018 and 2017, Barry C. Kaye was awarded Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

At March 31, 2018 the Company owed deferred compensation to an employee in the amount of $22,000, payment of which is being deferred until the Company has sufficient working capital. This amount is included in deferred compensation in the accompanying balance sheet at March 31, 2018.

XML

Contractual Obligations and Commitments

3 Months Ended

Mar. 31, 2018

Contractual Obligations and Commitments [Abstract]

CONTRACTUAL OBLIGATIONS AND COMMITMENTS

21. CONTRACTUAL OBLIGATIONS AND COMMITMENTS

The following table summarizes the Company’s contractual obligations and commitments at March 31, 2018:

	Total		2018		2019
Deferred compensation	$	1,708,000	$	1,708,000	$	-
Promissory notes to related parties		1,418,000		1,418,000		-
Mortgage loan payable		1,258,000		1,258,000		-
Convertible promissory notes		392,000		340,000		52,000
Total	$	4,776,000	$	4,724,000	$	52,000

XML

Litigation and Contingencies

3 Months Ended

Mar. 31, 2018

Litigation and Contingencies [Abstract]

LITIGATION AND CONTINGENCIES

22. LITIGATION AND CONTINGENCIES

The Company is not a party to any litigation that is material to its business.

XML

Recently Issued Accounting Standards

3 Months Ended

Mar. 31, 2018

Recently Issued Accounting Standards [Abstract]

RECENTLY ISSUED ACCOUNTING STANDARDS

23. RECENTLY ISSUED ACCOUNTING STANDARDS

Revenue Recognition

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled to when products are transferred to customers. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606) – Deferral of the Effective Date, which defers the effective date of ASU 2014-09 for one year and permits early adoption. The Company intends to adopt this standard in its first quarter of 2019.

In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606) – Identifying Performance Obligations and Licensing (“ASU 2016-10”), which amends the guidance in ASU 2014-09 related to identifying performance obligations and accounting for licenses of intellectual property. The Company will adopt ASU 2016-10 with ASU 2014-09. The Company is currently evaluating the impact of adopting the new revenue recognition standard, as amended, but does not expect it to have a material impact on its financial statements.

Stock Compensation

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. The Company is currently evaluating the impact of adopting the new stock compensation standard, but does not expect it to have a material impact on its financial statements.

Financial Instruments

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10) (“ASU 2016-01”), which updates certain aspects of recognition, measurement, presentation and disclosure of financial instruments. ASU 2016-01 will be effective for the Company beginning in its first quarter of 2019. The Company does not believe the adoption of the new financial instruments standard will have a material impact on its financial statements.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2018

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

24. SUBSEQUENT EVENTS

Certificate of Validation

On April 2, 2018, the Company filed a certificate of validation with the state of Delaware which had retroactive effect to the close of trading in the Corporation’s common stock on December 1, 2017, in order to:

(i)	cure certain technical, procedural defects related to the 1:200 reverse stock split, which became effective at the close of trading on December 31, 2017,
(ii)	clarify that the reverse stock split effected a 1:200 reduction in the number of the Corporation’s authorized shares of common stock, from 12,000,000,000 to 60,000,000, with retroactive effect to the close of trading on December 1, 2017,
(iii)	clarify that the reverse stock split effected 1:200 reduction in the number of authorized shares of the Corporation’s preferred stock, from 100,000,000 to 500,000 with retroactive effect to the close of trading on December 1, 2017; and,
(iv)	concurrently therewith, further amend the Corporation’s Amended Certificate of Articles of Incorporation with the State of Delaware to increase the number of the Corporation’s authorized shares of common stock, par value $0.0001 from 60,000,000 to 120,000,000 and reduce the number of authorized shares of the Corporation’s preferred stock, par value $0.001 from 500,000 to 350,000.

The above corporate action was authorized by the board of directors on February 28, 2018, and by means of obtaining the written consent of George J. Coates, the sole majority stockholder, was approved by the shareholders on March 1, 2018.

Certificate of Conversion and Certificate of Designation

On May 9, 2018, the Company filed a Certificate of Conversion and a Certificate of Designation which caused the following corporate actions to become effective:

(i)	The Corporation’s State of Domicile was converted from the State of Delaware to the State of Nevada.
(ii)	The number of authorized shares of capital stock of the Company was increased to:

a. 2,400,000,000 shares of common stock, par value $0.0001 per share

b. 100,000,000 shares of preferred stock, par value $0.001 per share

(iii) The series and number of shares of preferred stock designated from the 100,000,000 shares of preferred stock authorized, was increased to:

a. 1,000,000 shares of Series A Preferred Stock, $0.001 per share

b. 10,000,000 shares of Series B Convertible Preferred Stock, $0.001 per share

Section 3(a)10 Exempt Securities Transaction

On March 19, 2018, the Company entered into a Settlement Agreement and Stipulation (the “Settlement Agreement”) with Livingston Asset Management LLC, a Florida limited liability company (“LAM”), pursuant to which the Company agreed to issue common stock to LAM in exchange for the settlement of $69,000 (the “Settlement Amount”) of past-due obligations and accounts payable of the Company. LAM purchased the obligations and accounts payable from certain vendors of the Company as described below.

On April 2, 2018, the Circuit Court of Baltimore County, Maryland (the “Court”), entered an order (the “LAM Order”) approving, among other things, the fairness of the terms and conditions of an exchange in reliance upon an exemption from registration provided for in Section 3(a)(10) of the Securities Act of 1933, as amended (the “Securities Act”), in accordance with a stipulation of settlement, pursuant to the Settlement Agreement between the Company and LAM. Pursuant to the court order, LAM commenced an action against the Company to recover an aggregate of $69,000 of past-due obligations and accounts payable of the Company, which LAM had purchased from certain vendors of the Company pursuant to the terms of separate claim purchase agreements between LAM and each of such vendors (the “LAM Assigned Accounts”). The LAM Assigned Accounts relate to certain accounting services provided to the Company and a supplier invoice. The Settlement Agreement became effective and binding upon the Company and LAM upon execution of the Order by the Court on April 2, 2018.

Pursuant to the terms of the Settlement Agreement approved by the LAM Order, on April 2, 2018, the Registrant agreed to issue shares to LAM (the “LAM Settlement Shares”) of the Registrant’s common stock at a 30% discount from the selling price of the settlement shares sold by LAM, as defined in the settlement agreement. The Settlement Agreement provides that the LAM Settlement Shares will be issued in one or more tranches, as necessary, sufficient to satisfy the settlement amount through the issuance of freely trading securities issued in reliance upon an exemption provided for in Section 3(a)(10) of the Securities Act. The parties reasonably estimate that the fair market value of the LAM Settlement Shares to be received by LAM is equal to approximately $99,000. Additional tranche requests shall be made as requested by LAM until the LAM Settlement Amount is paid in full.

The Settlement Agreement provides that in no event shall the number of shares of Common Stock issued to LAM or its designee in connection with the Settlement Agreement, when aggregated with all other shares of Common Stock then beneficially owned by LAM and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder), result in the beneficial ownership by LAM and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and the rules and regulations thereunder) at any time of more than 9.99% of the Common Stock.

The Company is required to reserve a sufficient number of shares of its Common Stock to provide for issuances thereof, upon full satisfaction of the Settlement Amount.

During the period from April 6, 2018 through May 14, 2018, the Company issued 8,970,000 shares of Common Stock to LAM to be sold in the open market in reliance upon an exemption provided for in Section 3(a)(10) of the Securities Act. Proceeds from the sales are to be used to satisfy past-due obligations of the Company previously assigned to LAM. During the period from April 6, 2018 through May 14, 2018, Lam has paid $40,000 of the Settlement Amount of the Company's past due obligations in accordance with the Settlement Agreement.

Conversion of Convertible Promissory Notes

During the period from April 1, 2018 to May 14, 2018, $29,000 principal amount of convertible promissory notes, including accrued interest, was converted into 5,068,261 unregistered, restricted shares of the Company’s common stock.

Issuances of Promissory Notes to Related Parties

During the period from April 1, 2018 to May 14, 2018, the Company issued promissory notes to George J. Coates and received aggregate cash proceeds of $1,000. During the period from April 1, 2018 to May 14, 2018, the Company issued promissory notes to Bernadette Coates and received aggregate cash proceeds of $11,000. The promissory notes are payable on demand and provide for interest at the rate of 17% per annum, compounded monthly.

Deferred Compensation

During the period from April 1, 2018 to May 14, 2018, George J. Coates, Gregory G. Coates, Barry C. Kaye and one employee agreed to additional deferral of their compensation amounting to $34,000, $10,000, $22,000 and $4,000, respectively.

XML

The Company and Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2018

The Company and Basis of Presentation [Abstract]

Nature of Organization

Nature of Organization

Coates International, Ltd. (the “Company” or “CIL”) has acquired the exclusive licensing rights to the patented Coates spherical rotary valve (“CSRV^®”) system technology in North America, Central America and South America (the “CSRV^® License”). The CSRV^® system technology has been developed over a period of more than 20 years by the Company’s founder George J. Coates, President and Chief Executive Officer, and his son Gregory G. Coates. The CSRV^® system technology is adaptable for use in piston-driven internal combustion engines of many types and has been patented in the United States and numerous countries throughout the world. The Company is endeavoring to raise working capital to commence production of hydrogen gas and natural gas powered CSRV^® industrial electric power generator sets (“Gen Sets)” and is also seeking to enter into sublicense agreements with third party, original equipment manufacturers (“OEM’s”) which provide for licensing fees. The Company is also continuing with research and development of a hydrogen reactor to harvest Hydroxy-Gas from water with the intent to power the Company’s products, including large industrial Gen Sets. George J. Coates, owner of the hydrogen reactor technology, has committed to license this technology to the Company once the related patent protection is in place.

Management believes that the CSRV^® engines provide the following advantages as compared to conventional internal combustion engines designed with “poppet valves”:

● Improved fuel efficiency

● Lower levels of harmful emissions

● Adaptability to numerous types of engine fuels

● Longer engine life

● Longer intervals between engine servicing

The CSRV^® system technology is designed to replace the intake and exhaust conventional “poppet valves” currently used in almost all piston-driven, automotive, truck, motorcycle, marine and electric power generator engines, among others. Unlike conventional valves which protrude into the engine combustion chamber, the CSRV^® system technology utilizes spherical valves that rotate in a cavity formed between a two-piece cylinder head. The CSRV^® system technology utilizes significantly fewer moving parts than conventional poppet valve assemblies. As a result of these design improvements, management believes that engines incorporating the CSRV^® system technology (“CSRV^® Engines”) will last significantly longer and will require less lubrication over the life of the engine, as compared to conventional engines. In addition, CSRV^® Engines can be designed with larger openings into the engine cylinder than with conventional valves so that more fuel and air can be inducted into, and expelled from the cylinder in a shorter period of time. Larger valve openings permit higher revolutions-per-minute (RPM’s) and permit higher compression ratios with lower combustion chamber temperatures, allowing the Coates Engine^® to produce more power than equivalent conventional engines. The extent to which CSRV^® Engines operating with the CSRV^® system technology achieve (i) higher RPM’s, (ii) greater volumetric efficiency and (iii) thermal efficiency than conventional engines, is a function of the engine design and application.

Basis of Presentation

Basis of Presentation

The accompanying condensed financial statements include the accounts of the Company. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed financial statements have been reclassified to conform to the current period’s presentation.

These condensed financial statements and accompanying notes should be read in conjunction with the Company’s annual financial statements and the notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2017 and the Company’s quarterly financial statements and the notes thereto included in its Quarterly Reports.

Since the Company’s inception, the Company has been responsible for the development costs of the CSRV^® technology in order to optimize the value of the licensing rights and has incurred related operational costs, the bulk of which have been funded primarily through cash generated from licensing fees, sales of stock, short term convertible promissory notes, capital contributions, loans made by George J. Coates, Bernadette Coates, his spouse, Gregory G. Coates and certain directors, fees received from research and development of prototype models and a small number of CSRV^® engine generator sales. The Company has incurred substantial cumulative losses from operations since its inception. Losses from operations are expected to continue until the CSRV^® Engines^® are successfully introduced into the marketplace enabling the Company to generate substantial sales and/or receive substantial licensing revenues. These losses from operations were primarily related to research and development of the Company’s intellectual property rights, patent filing and maintenance costs and general and administrative expenses. The Company has also reported substantial non-cash expenses for stock-based compensation, remeasurement of the estimated fair value of embedded derivative liabilities related to convertible promissory notes issued and interest expense and losses on conversion of convertible promissory notes.

As shown in the accompanying financial statements, the Company has incurred recurring losses from operations and, as of March 31, 2018, had a stockholders’ deficiency of ($6,376,000). In addition, our mortgage loan which had a principal balance of $1,258,000 at March 31, 2018, matures in July 2018. The Company will be required to renegotiate the terms of an extension of the mortgage loan or successfully refinance the property with another mortgage lender, if possible. Failure to do so could adversely affect the Company’s financial position and results of operations. In addition, the recent trading price range of the Company’s common stock has introduced additional difficulty to the Company’s challenge to secure needed additional working capital. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has instituted a cost control program intended to restrict variable costs to only those expenses that are necessary to complete its activities related to entering the production phase of operations, develop additional commercially feasible applications of the CSRV^®system technology, seek additional sources of working capital and cover general and administrative costs in support of such activities. The Company has been actively undertaking efforts to secure new sources of working capital. At March 31, 2018, the Company had negative working capital of ($7,786,000) compared with negative working capital of ($7.467,000) at the end of 2017.

The Company continues to actively seek out new sources of working capital; however, there can be no assurance that it will be successful in these efforts. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Reverse Stock Split

Reverse Stock Split

The Company effected a one-for-200 reverse stock split of all of its outstanding shares of common stock, Series A Preferred Stock, Series B Convertible Preferred Stock, common stock warrants and stock options as of the close of trading on December 1, 2017. All prior year balances of shares of capital stock, warrants and stock options outstanding and all presentations and disclosures of transactions in shares of capital stock, warrants and stock options have been restated on a pro forma basis as if the reverse stock split had occurred prior to January 1, 2017. Such restatements include calculations regarding the Company’s weighted average shares outstanding and loss per share.

Inventory

Inventory

Inventory consists of raw materials and work-in-process, including overhead. Inventory is stated at the lower of cost or net realizable value. Inventory is accounted for on the first-in, first-out method.

Use of Estimates

Use of Estimates

The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These significant estimates include determining the fair value of convertible promissory notes containing embedded derivatives and variable conversion rates, determining a value for shares of Series A Preferred Stock and Series B Convertible Preferred Stock issued, assigning useful lives to the Company’s property, plant and equipment, determining an appropriate amount to reserve for obsolete and slow moving inventory, estimating a valuation allowance for deferred tax assets, assigning expected lives to, and estimating the rate of forfeitures of, stock options granted and selecting a trading price volatility factor for the Company’s common stock in order to estimate the fair value of the Company’s stock options on the date of grant or other appropriate measurement date. Actual results could differ from those estimates.

XML

Agreement Assigned to Almont Energy, Inc. (Tables)

3 Months Ended

Mar. 31, 2018

Agreement Assigned to Almont Energy, Inc. [Abstract]

Summary of amortization

Year Ending	Amount
2018		14,000
2019		19,000
2020		19,000
2021		19,000
Thereafter		94,000
	$	165,000

XML

Inventory (Tables)

3 Months Ended

Mar. 31, 2018

Inventory [Abstract]

Summary of inventory

	March 31, 2018		December 31, 2017
Raw materials	$	102,000	$	104,000

XML

Property, Plant and Equipment (Tables)

3 Months Ended

Mar. 31, 2018

Property, Plant and Equipment [Abstract]

Summary of property, plant and equipment

	March 31, 2018			December 31,  2016
Land	$	1,235,000		$	1,235,000
Building		964,000			964,000
Building improvements		83,000			83,000
Machinery and equipment		689,000			689,000
Furniture and fixtures		57,000			57,000
		3,028,000			3.028,000
Less:  Accumulated depreciation		(1,006,000	)		(996,000	)
Total	$	2,022,000		$	2,032,000

XML

Accounts Payable and Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2018

Accounts Payable and Accrued Liabilities [Abstract]

Summary of accounts payable and accrued liabilities

	March 31, 2018		December 31, 2017
Legal and professional fees	$	1,396,000	$	1,427,000
Accrued interest expense		622,000		582,000
General and administrative expenses		528,000		420,000
Research and development costs		115,000		115,000
Total	$	2,661,000	$	2,544,000

XML

Convertible Promissory Notes and Embedded Derivative Liability (Tables)

3 Months Ended

Mar. 31, 2018

Convertible Promissory Notes and Embedded Derivative Liability [Abstract]

Schedule of fair value hierarchy of financial assets and liabilities measured at fair value

	March 31, 2018		December 31, 2017
Level 1 Inputs	$	-	$	-
Level 2 Inputs		497,000		359,000
Level 3 Inputs		-		-
Total	$	497,000	$	359,000

XML

Capital Stock (Tables)

3 Months Ended

Mar. 31, 2018

Capital Stock/Stock Options [Abstract]

Schedule of conversion into shares of common stock

	Total		2018		2019		2020
George J. Coates		260,020		74,506		136,599		48,915
Gregory G. Coates		19,832		5,484		10,646		3,702
Barry C. Kaye		1,526		413		823		290
Total		281,378		80,403		148,068		52,907

XML

Stock Options (Tables)

3 Months Ended

Mar. 31, 2018

Capital Stock/Stock Options [Abstract]

Summary of stock options outstanding under the company's stock option plans

	Exercise Price Per Share		Number Outstanding		Weighted Average Remaining Contractual Life		Number Exercisable		Weighted Average Exercise Price		Weighted Average Fair Value Per Stock Option at Date of Grant
Balance, 3/31/18	$	5.60 – $88.00		62,500		9		62,500	$	36.34	$	33.84

Summary of assumptions used to determine weighted average fair value

●	Historical stock price volatility	139% - 325%
●	Risk-free interest rate	0.21% - 4.64%
●	Expected life (in years)	4
●	Dividend yield	$0.00

● Historical stock price volatility: The Company utilized the volatility in the trading of its common stock computed for the 12 months of trading immediately preceding the date of grant.

● Risk-free interest rate: The Company bases the risk-free interest rate on the interest rate payable on U.S. Treasury securities in effect at the time of the grant for a period that is commensurate with the assumed expected option life.

● Expected life: The expected life of the options represents the period of time options are expected to be outstanding. The Company has very limited historical data on which to base this estimate. Accordingly, the Company estimated the expected life based on its assumption that the executives will be subject to frequent blackout periods during the time that the stock options will be exercisable and based on the Company’s expectation that it will complete its research and development phase and commence its initial production phase. The vesting period of these options was also considered in the determination of the expected life of each stock option grant.

● No expected dividends.

XML

Related Party Transactions (Tables)

3 Months Ended

Mar. 31, 2018

Related Party Transactions [Abstract]

Summary of approximate amount of base compensation and benefits

	For the three months ended March 31,
	2018		2017
George J. Coates (a) (b)	$	4,000	$	14,000
Gregory G. Coates (c) (d)		24,000		3,000
Bernadette Coates (e)		-		-

(a) For the three months ended March 31, 2018 and 2017, George J. Coates earned additional base compensation of $63,000 and $53,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $1,283,000 and $1,221,000, respectively.

(b) During the three months ended March 31, 2018 and 2017, George J. Coates was awarded Series A Preferred Stock and Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

(c) For the three months ended March 31, 2018 and 2017, Gregory G. Coates earned additional base compensation of $19,000 and $38,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $161,000 and $143,000, respectively.

(d) During the three months ended March 31, 2018 and 2017, Gregory G. Coates was awarded Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

(e) The Company had been deferring base compensation for Bernadette Coates, who retired in 2016, until it has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $242,000.

XML

Contractual Obligations and Commitments (Tables)

3 Months Ended

Mar. 31, 2018

Contractual Obligations and Commitments [Abstract]

Summary of contractual obligations and commitments

	Total		2018		2019
Deferred compensation	$	1,708,000	$	1,708,000	$	-
Promissory notes to related parties		1,418,000		1,418,000		-
Mortgage loan payable		1,258,000		1,258,000		-
Convertible promissory notes		392,000		340,000		52,000
Total	$	4,776,000	$	4,724,000	$	52,000

XML

The Company and Basis of Presentation (Details) - USD ($)		3 Months Ended
	Dec. 01, 2017	Mar. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
The Company and Basis of Presentation (Textual)
Stockholder's deficiency		$ (6,376,000)	$ (6,009,408)	$ 81	$ 18
Negative working capital		(7,786,000)	(7,467,000)
Mortgage loan of principal balance		$ 1,258,000	$ 1,273,000
Maturity date		Jul. 31, 2018
System technology developed over a period		20 years
Reverse stock split, description	A 1:200 reverse stock split of all of the Company's shares of common stock, shares of preferred stock, common stock warrants and stock options became effective.	The Company effected a one-for-200 reverse stock split of all of its outstanding shares of common stock, Series A Preferred Stock, Series B Convertible Preferred Stock, common stock warrants and stock options as of the close of trading on December 1, 2017.

XML

Licensing Agreement and Deferred Licensing Costs (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Licensing Agreement and Deferred Licensing Costs (Textual)
Accumulated amortization	$ 33,000		$ 34,000
Amortization expense	$ 1,000	$ 1,000

XML

Agreement Assigned to Almont Energy, Inc. (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Agreement Assigned to Almont Energy, Inc. [Abstract]
2018	$ 14,000
2019	19,000
2020	19,000
2021	19,000
Thereafter	94,000
Amortization amount	$ 165,000	$ 170,000

XML

Agreement Assigned to Almont Energy, Inc. (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Agreement Assigned to Almont Energy, Inc. (Textual)
Unamortized balance of license deposit	$ 165,000	$ 170,000
Sublicense deposits under current assets	19,000	$ 19,000
Canadian License [Member]
Agreement Assigned to Almont Energy, Inc. (Textual)
Amount of non-refundable deposit received in prior years	$ 300,000

XML

Non-Exclusive Distribution Sublicense with Renown Power Development, Ltd. (Details) - USD ($)	1 Months Ended
	Feb. 28, 2015	Mar. 31, 2018
Renown Power Development, Ltd. [Member]
Non-Exclusive Distribution Sublicense with Renown Power Development, Ltd. (Textual)
Amount of non-refundable deposit received in prior years		$ 500,000
Coates Power [Member]
Non-Exclusive Distribution Sublicense with Renown Power Development, Ltd. (Textual)
Deposit on order for two completed gen sets received in prior years	$ 131,000

XML

Other Current Assets (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Other Current Assets (Textual)
Other current assets	$ 50,446	$ 608
Inventory billed, but not received	$ 48,000

XML

Inventory (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Summary of inventory
Raw materials	$ 102,000	$ 104,000

XML

License Deposits (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
License Deposits [Member]
License Deposits (Textual)
Sublicensing fee revenue	$ 5,000	$ 5,000

XML

Property, Plant and Equipment (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Summary of Property, plant and equipment
Property, plant and equipment, Gross	$ 3,028,000	$ 3,028,000
Less: Accumulated depreciation	(1,006,000)	(996,000)
Total	2,022,000	2,032,000
Land [Member]
Summary of Property, plant and equipment
Property, plant and equipment, Gross	1,235,000	1,235,000
Building [Member]
Summary of Property, plant and equipment
Property, plant and equipment, Gross	964,000	964,000
Building improvements [Member]
Summary of Property, plant and equipment
Property, plant and equipment, Gross	83,000	83,000
Machinery and equipment [Member]
Summary of Property, plant and equipment
Property, plant and equipment, Gross	689,000	689,000
Furniture and fixtures [Member]
Summary of Property, plant and equipment
Property, plant and equipment, Gross	$ 57,000	$ 57,000

XML

Property, Plant and Equipment (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Property, Plant and Equipment (Textual)
Depreciation expense	$ 10,000	$ 11,000

XML

Mortgage Loan Payable (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Mortgage Loan Payable (Textual)
Maturity date	Jul. 31, 2018
Mortgage loan payable, interest rate	7.50%
Interest expense	$ 24,000	$ 25,000
Mortgage loan payment terms	Monthly payments of interest, plus $5,000 which is being applied to the principal balance.
Monthly payment of principal	$ 5,000
Principal balance of mortgage loan due	$ 1,258,000		$ 1,273,000
Shares of common stock owned by George J. Coates pledged as collateral	25,000

XML

Accounts Payable and Accrued Liabilities (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Summary of accounts payable and accrued liabilities
Legal and professional fees	$ 1,396,000	$ 1,427,000
Accrued interest expense	622,000	582,000
General and administrative expenses	528,000	420,000
Research and development costs	115,000	115,000
Total	$ 2,661,000	$ 2,544,000

XML

Promissory Notes to Related Parties (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Feb. 28, 2018
George J. Coates [Member]
Promissory Notes to Related Parties (Textual)
Cash proceeds from related party promissory notes	$ 0	$ 4,000
Repaid promissory notes principal amount	$ 20,000	4,000
Promissory note, interest rate	17.00%
Principal amount, outstanding	$ 0
Interest expense during the period	13,000	13,000
Unpaid balance of accrued interest on promissory notes	331,000
Gregory G. Coates [Member]
Promissory Notes to Related Parties (Textual)
Repaid promissory notes principal amount	$ 15,000	0
Promissory note, interest rate	10.00%
Promissory notes, interest expense	$ 35,000	35,000
Outstanding principal balance	1,403,000
Bernadette Coates [Member]
Promissory Notes to Related Parties (Textual)
Cash proceeds from related party promissory notes	0	1,000
Repaid promissory notes principal amount	$ 15,000	6,000
Promissory note, interest rate	17.00%
Promissory notes, interest expense	$ 7,000	$ 3,000
Outstanding principal balance	14,000
Employee [Member]
Promissory Notes to Related Parties (Textual)
Promissory note, interest rate			17.00%
Interest expense during the period			$ 1,400
Promissory Notes [Member]
Promissory Notes to Related Parties (Textual)
Unpaid balance of accrued interest on promissory notes	$ 432,000

XML

Promissory Note (Details) - USD ($)		1 Months Ended
	May 05, 2017	Mar. 31, 2017
Promissory Note (Textual)
Promissory note, issued		$ 25,000
Promissory note, maturity date		May 13, 2017
Promissory note interest payable with unregistered shares of common stock		10,000,000
Number of warrants held by lender extended for five years with modified exercise price		10,839,752
Promissory note additional term		Five years
Original expiration date of warrants extended		2017
Restricted shares of common stock issued in payment of interest	8,688,525
Interest expense on promissory notes	$ 4,000
Extended warrants modified exercise price, per share		$ 0.03

XML

Convertible Promissory Notes and Embedded Derivative Liability (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Financial assets and liabilities measured at fair value
Total	$ 497,000	$ 359,000
Level 1 Inputs [Member]
Financial assets and liabilities measured at fair value
Total
Level 2 Inputs [Member]
Financial assets and liabilities measured at fair value
Total	497,000	359,000
Level 3 Inputs [Member]
Financial assets and liabilities measured at fair value
Total

XML

Convertible Promissory Notes and Embedded Derivative Liability (Details Textual) - USD ($)

3 Months Ended

May 09, 2018

Mar. 31, 2018

Mar. 31, 2017

Dec. 31, 2017

Convertible Promissory Notes and Embedded Derivative Liability (Textual)

Principal balance of convertible note with post-conversion remeasurement provisions

$ 385,000

Subsequent Events [Member]

Convertible Promissory Notes and Embedded Derivative Liability (Textual)

Certificate of conversion and designation, description

(i)	The Corporation’s State of Domicile was converted from the State of Delaware to the State of Nevada.
(ii)	The number of authorized shares of capital stock of the Company was increased to:

a. 2,400,000,000 shares of common stock, par value $0.0001 per share

b. 100,000,000 shares of preferred stock, par value $0.001 per share

(iii) The series and number of shares of preferred stock designated from the 100,000,000 shares of preferred stock authorized, was increased to:

a. 1,000,000 shares of Series A Preferred Stock, $0.001 per share

b. 10,000,000 shares of Series B Convertible Preferred Stock, $0.001 per share

Convertible promissory notes [Member]

Convertible Promissory Notes and Embedded Derivative Liability (Textual)

Principal balance of convertible note with post-conversion remeasurement provisions

$ 287,000

$ 93,000

Conversion price, description for convertible note payable

Outstanding notes may be converted into unregistered shares of the Company's common stock at a discount ranging from 30% to 39% of the defined trading price of the common stock on the date of conversion. The defined trading prices are based on the trading price of the stock during a defined period ranging from ten to twenty-five trading days immediately preceding the date of conversion.

Unamortized discount

$ 116,000

$ 52,000

Convertible promissory notes with an aggregate principal balance

$ 82,000

$ 56,000

Convertible promissory notes ,accrued interest converted

8,357,452

854,365

Loss on conversion of convertible notes

$ 21,000

$ 12,000

Prepayment option, description

Convertible notes generally become convertible, in whole, or in part, beginning on the six month anniversary of the issuance date and may be prepaid at the option of the Company, with a prepayment penalty ranging from 15% to 50% of the principal amount of the convertible note at any time prior to becoming eligible for conversion.

Common stock reserved for unissued

160,748,286

Estimated volatility rate

200.00%

Certificate of conversion and designation, description

This was due to the filing of a Certificate of Validation with the Secretary of State of Delaware on April 2, 2018, as more fully discussed in Note 24, which reduced the number of authorized shares of common stock from 12,000,000,000 to 120,000,000. This reduction was retroactive to the close of trading in the Company's common stock on December 1, 2017. The Company has obtained 90-day waivers of this default from each of the convertible noteholders. As discussed in more detail in Note 24, on May 7, 2018, the Company filed a Notice of Conversion with the Secretary of State of Nevada, which increased the number of authorized shares of the Company's common stock from 120,000,000 to 2,400,000,000, thereby automatically curing this default condition for all convertible notes.

Outstanding convertible notes eligible for conversion

$ 149,000

Convertible promissory notes [Member] | Maximum [Member]

Convertible Promissory Notes and Embedded Derivative Liability (Textual)

Conversion price discount from defined trading price

39.00%

Effective interest rate

147.00%

Convertible promissory notes [Member] | Minimum [Member]

Convertible Promissory Notes and Embedded Derivative Liability (Textual)

Conversion price discount from defined trading price

30.00%

Effective interest rate

107.00%

Convertible promissory note one [Member]

Convertible Promissory Notes and Embedded Derivative Liability (Textual)

Principal balance of convertible note with post-conversion remeasurement provisions

$ 53,000

Conversion price, description for convertible note payable

This convertible note also requires that the conversion price be re-measured 23 trading days after the conversion shares are originally delivered.

XML

Capital Stock (Details)	3 Months Ended
	Mar. 31, 2018 shares
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	281,378
2018 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	80,403
2019 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	148,068
2020 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	52,907
George J. Coates [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	260,020
George J. Coates [Member] | 2018 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	74,506
George J. Coates [Member] | 2019 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	136,599
George J. Coates [Member] | 2020 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	48,915
Gregory G. Coates [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	19,832
Gregory G. Coates [Member] | 2018 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	5,484
Gregory G. Coates [Member] | 2019 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	10,646
Gregory G. Coates [Member] | 2020 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	3,702
Barry C. Kaye [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	1,526
Barry C. Kaye [Member] | 2018 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	413
Barry C. Kaye [Member] | 2019 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	823
Barry C. Kaye [Member] | 2020 [Member]
Number of shares of stock becoming eligible for conversion to shares of common stock by year [Line Items]
Total	290

XML

Capital Stock (Details Textual) - USD ($)			3 Months Ended
	Dec. 01, 2017	May 05, 2017	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Capital Stock (Textual)
Common stock, authorized shares			120,000		120,000
Common stock, par value			$ 0.0001		$ 0.0001
Reverse stock split, description	A 1:200 reverse stock split of all of the Company's shares of common stock, shares of preferred stock, common stock warrants and stock options became effective.		The Company effected a one-for-200 reverse stock split of all of its outstanding shares of common stock, Series A Preferred Stock, Series B Convertible Preferred Stock, common stock warrants and stock options as of the close of trading on December 1, 2017.
Preferred stock, authorized shares			350,000		350,000
Preferred stock, par value			$ 0.001		$ 0.001
Pro forma information for series B convertible preferred stock, description			Once the conversion restrictions lapse, an additional 281,378,000 new restricted shares of common stock would be issued. On a pro forma basis, based on the number of shares of common stock outstanding at March 31, 2018, this would dilute the ownership percentage of non-affiliated stockholders from 85.4% to 12.8%.
Shares of series B stock outstanding that could be converted to common stock once all restrictions lapse			281,378
Issuance of restricted shares of common stock for interest expense		8,688,525
Series A Preferred Stock [Member]
Capital Stock (Textual)
Series A preferred stock, designated shares			5,000		5,000
Series A convertible preferred stock, issued shares			3,601		3,601
Series A Convertible preferred stock, outstanding shares			3,601		3,601
Description of preferred stock voting rights			Shares of Series A entitle the holder to 10,000 votes per share on all matters brought before the shareholders for a vote.
Series B Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, par value			$ 0.001		$ 0.001
Series B convertible preferred stock, designated shares			345,000		345,000
Series B Convertible preferred stock, issued shares			281,378		228,471
Series B Convertible preferred stock, outstanding shares			281,378		228,471
Number shares of common stock into which each share of Series B Convertible Preferred Stock can be converted			1,000
Description of preferred stock voting rights			Holders of the Series B are entitled to one thousand votes per share held on all matters brought before the shareholders for a vote.
Percentage of non - affiliate shareholder ownership before assumed conversion			85.40%
Percentage of non - affiliate shareholder ownership after assumed conversion			12.80%
Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, authorized shares			100,000,000
Common stock [Member]
Capital Stock (Textual)
Common stock, authorized shares			120,000,000
Common stock, par value			$ 0.0001
Convertible promissory note [Member]
Capital Stock (Textual)
Unregistered, restricted shares of common shares issued upon conversion of convertible promissory notes			8,357,452	854,365
Principal amount of convertible debt, including accrued interest converted into shares of common stock			$ 82,000	$ 56,000
Amount principal and interest on convertible notes converted to common stock before resxision			$ 149,000
George J. Coates [Member]
Capital Stock (Textual)
Shares of series B stock outstanding that could be converted to common stock once all restrictions lapse			260,020
George J. Coates [Member] | Series A Preferred Stock [Member]
Capital Stock (Textual)
Description of preferred stock voting rights			All outstanding shares of Series A are owned by George J. Coates, which entitle him to 36,010,000 million votes in addition to his voting rights from the shares of common stock and the shares of Series B he holds.
Number of shares of Series A Preferred Stock granted				3,351
Percentage of eligible votes				85.70%
George J. Coates [Member] | Series B Preferred Stock [Member]
Capital Stock (Textual)
Series B stock, issued shares			48,915	3,861
Fixed ownership percentage			80.63%
Estimated fair value of Series B convertible preferred stock granted			$ 545,000	$ 132,000
Gregory G. Coates [Member]
Capital Stock (Textual)
Shares of series B stock outstanding that could be converted to common stock once all restrictions lapse			19,832
Gregory G. Coates [Member] | Series B Preferred Stock [Member]
Capital Stock (Textual)
Series B stock, issued shares			3,702	597
Fixed ownership percentage			6.10%
Estimated fair value of Series B convertible preferred stock granted			$ 41,000	$ 39,000
Barry C. Kaye [Member]
Capital Stock (Textual)
Shares of common stock issued upon conversion of Series B shares				6.86
Shares of common stock issued upon conversion of shares of Series B Convertible preferred stock				6,868
Shares of series B stock outstanding that could be converted to common stock once all restrictions lapse			1,526
Barry C. Kaye [Member] | Series B Preferred Stock [Member]
Capital Stock (Textual)
Series B stock, issued shares			290	47
Fixed ownership percentage			0.048%
Estimated fair value of Series B convertible preferred stock granted			$ 3,000	$ 3,000
Shares of common stock issued upon conversion of shares of Series B Convertible preferred stock				6,860

XML

Loss Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Loss Per Share (Textual)
Warrants outstanding to purchase common stock	741,725	751,725
Vested stock options outstanding	62,350	62,350
Exercise prices, description	Stock warrants outstanding to purchase 738,153 shares of common stock at exercise prices ranging from $0.10 to $13.50 per share.	Stock warrants outstanding to purchase 751,725 shares of common stock at exercise prices ranging from $0.10 to $13.50 per share.
Convertible promissory notes [Member]
Loss Per Share (Textual)
Convertible promissory notes outstanding, eligible for conversion	$ 385,000	$ 140,000
Pro forma number of common shares issuable upon assumed conversion of promissory notes eligible for conversion	33,314,645	3,257,093
Maximum [Member]
Loss Per Share (Textual)
Stock option exercise price	$ 88.00	$ 88.00
Minimum [Member]
Loss Per Share (Textual)
Stock option exercise price	$ 5.60	$ 5.60

XML

Stock Options (Details) - Stock Option [Member]	3 Months Ended
	Mar. 31, 2018 $ / shares shares
Stock options outstanding under stock option plan
Number Outstanding | shares	62,500
Weighted Average Remaining Contractual Life	9 years
Number Exercisable | shares	62,500
Weighted Average Exercise Price	$ 36.34
Weighted Average Fair Value Per Stock Option at Date of Grant	33.84
Minimum [Member]
Stock options outstanding under stock option plan
Exercise Price Per Share	5.60
Maximum [Member]
Stock options outstanding under stock option plan
Exercise Price Per Share	$ 88.00

XML

Stock Options (Details 1)	3 Months Ended
	Mar. 31, 2018
Summary of assumptions used to determine weighted average fair value
Historical stock price volatility, minimum	139.00%	[1]
Historical stock price volatility, maximum	325.00%	[1]
Risk-free interest rate, minimum	0.21%	[2]
Risk-free interest rate, maximum	4.64%	[2]
Expected life (in years)	4 years	[3]
Dividend yield	0.00%	[4]

[1] Historical stock price volatility: The Company utilized the volatility in the trading of its common stock computed for the 12 months of trading immediately preceding the date of grant.

[2] Risk-free interest rate: The Company bases the risk-free interest rate on the interest rate payable on U.S. Treasury securities in effect at the time of the grant for a period that is commensurate with the assumed expected option life.

[3] Expected life: The expected life of the options represents the period of time options are expected to be outstanding. The Company has very limited historical data on which to base this estimate. Accordingly, the Company estimated the expected life based on its assumption that the executives will be subject to frequent blackout periods during the time that the stock options will be exercisable and based on the Company's expectation that it will complete its research and development phase and commence its initial production phase. The vesting period of these options was also considered in the determination of the expected life of each stock option grant.

[4] No expected dividends.

XML

Stock Options (Details Textual)	3 Months Ended
	Mar. 31, 2018 shares
Stock Options (Textual)
Historical stock price volatility, description	The Company utilized the volatility in the trading of its common stock computed for the 12 months of trading immediately preceding the date of grant.
2014 Stock Option and Incentive Plan [Member]
Stock Options (Textual)
Common stock available for stock options or awards under the stock plan	50,000,000
Maximum percentage of shares issuable in one year to one employee	25.00%
Maximum number of shares of common stock authorized for issue under plan	50,000,000

XML

Income Taxes (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Income Taxes (Textual)
Increased in deferred tax assets	$ 247,000	$ 833,000
Open income tax years, Description	2014 through 2016.
Future federal taxable income [Member]
Income Taxes (Textual)
Operating loss carryforwards	$ 20,908,000
Operating loss carryforwards expiration date, description	Expiring between 2018 and 2038.
Future state taxable income [Member]
Income Taxes (Textual)
Operating loss carryforwards	$ 10,504,000
Operating loss carryforwards expiration date, description	Expiring between 2029 and 2038.

XML

Related Party Transactions (Details) - USD ($)		3 Months Ended
		Mar. 31, 2018	Mar. 31, 2017
George J. Coates [Member]
Summary of approximate amount of base compensation and benefits
Base compensation and benefits paid	[1],[2]	$ 4,000	$ 14,000
Gregory G. Coates [Member]
Summary of approximate amount of base compensation and benefits
Base compensation and benefits paid	[3],[4]	24,000	3,000
Bernadette Coates [Member]
Summary of approximate amount of base compensation and benefits
Base compensation and benefits paid	[5]

[1] During the three months ended March 31, 2018 and 2017, George J. Coates was awarded Series A Preferred Stock and Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

[2] For the three months ended March 31, 2018 and 2017, George J. Coates earned additional base compensation of $63,000 and $53,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $1,283,000 and $1,221,000, respectively.

[3] During the three months ended March 31, 2018 and 2017, Gregory G. Coates was awarded Series B Converted Preferred Stock for anti-dilution. The details are presented in Note 16.

[4] For the three months ended March 31, 2018 and 2017, Gregory G. Coates earned additional base compensation of $19,000 and $38,000, respectively, payment of which is being deferred until the Company has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $161,000 and $143,000, respectively.

[5] The Company had been deferring base compensation for Bernadette Coates, who retired in 2016, until it has sufficient working capital. The total amount of deferred compensation included in the accompanying balance sheets at March 31, 2018 and December 31, 2017, was $242,000.

XML

Related Party Transactions (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
George J. Coates [Member]
Related Party Transactions (Textual)
Amount of compensation deferred during the year	$ 63,000	$ 53,000
Amount of deferred compensation	1,283,000		$ 1,221,000
Patent maintenance costs related to licensing of intellectual property	$ 4,000	4,000
Promissory note, interest rate	17.00%
Gregory G. Coates [Member]
Related Party Transactions (Textual)
Balance of deferred compensation outstanding	$ 161,000		143,000
Amount of compensation deferred during the year	$ 19,000	38,000
Promissory note, interest rate	10.00%
Bernadette Coates [Member]
Related Party Transactions (Textual)
Balance of deferred compensation outstanding	$ 242,000		$ 242,000
Promissory note, interest rate	17.00%
Barry C. Kaye [Member]
Related Party Transactions (Textual)
Amount of compensation paid	$ 35,000	10,000
Compensation earned by Barry C. Kaye	33,000	32,000
Interest accrued on unpaid deferred compensation	18,000	$ 13,000
Total amount of unpaid, deferred compensation and accrued interest	434,000
Employee [Member]
Related Party Transactions (Textual)
Amount of deferred compensation	$ 22,000
Promissory note, interest rate	17.00%

XML

Contractual Obligations and Commitments (Details)	Mar. 31, 2018 USD ($)
Summary of contractual obligations and commitments
Total	$ 4,776,000
2018 [Member]
Summary of contractual obligations and commitments
Total	4,724,000
2019 [Member]
Summary of contractual obligations and commitments
Total	52,000
Deferred compensation [Member]
Summary of contractual obligations and commitments
Total	1,708,000
Deferred compensation [Member] | 2018 [Member]
Summary of contractual obligations and commitments
Total	1,708,000
Deferred compensation [Member] | 2019 [Member]
Summary of contractual obligations and commitments
Total
Promissory notes to related parties [Member]
Summary of contractual obligations and commitments
Total	1,418,000
Promissory notes to related parties [Member] | 2018 [Member]
Summary of contractual obligations and commitments
Total	1,418,000
Promissory notes to related parties [Member] | 2019 [Member]
Summary of contractual obligations and commitments
Total
Mortgage loan payable [Member]
Summary of contractual obligations and commitments
Total	1,258,000
Mortgage loan payable [Member] | 2018 [Member]
Summary of contractual obligations and commitments
Total	1,258,000
Mortgage loan payable [Member] | 2019 [Member]
Summary of contractual obligations and commitments
Total
Convertible promissory notes [Member]
Summary of contractual obligations and commitments
Total	392,000
Convertible promissory notes [Member] | 2018 [Member]
Summary of contractual obligations and commitments
Total	340,000
Convertible promissory notes [Member] | 2019 [Member]
Summary of contractual obligations and commitments
Total	$ 52,000

XML

Subsequent Events (Details) - USD ($)

1 Months Ended

3 Months Ended

May 09, 2018

May 05, 2017

May 14, 2018

Apr. 02, 2018

Mar. 19, 2018

Mar. 31, 2018

Subsequent Event [Line Items]

Estimated fair value of LAM settlement shares to be received by LAM

$ 69,000

Share issued of series B of common stock

8,688,525

Convertible Promissory Note [Member]

Subsequent Event [Line Items]

Certificate of conversion and designation, description

This was due to the filing of a Certificate of Validation with the Secretary of State of Delaware on April 2, 2018, as more fully discussed in Note 24, which reduced the number of authorized shares of common stock from 12,000,000,000 to 120,000,000. This reduction was retroactive to the close of trading in the Company's common stock on December 1, 2017. The Company has obtained 90-day waivers of this default from each of the convertible noteholders. As discussed in more detail in Note 24, on May 7, 2018, the Company filed a Notice of Conversion with the Secretary of State of Nevada, which increased the number of authorized shares of the Company's common stock from 120,000,000 to 2,400,000,000, thereby automatically curing this default condition for all convertible notes.

Subsequent Events [Member]

Subsequent Event [Line Items]

Certificate of Validation, description

(i)	cure certain technical, procedural defects related to the 1:200 reverse stock split, which became effective at the close of trading on December 31, 2017,
(ii)	clarify that the reverse stock split effected a 1:200 reduction in the number of the Corporation’s authorized shares of common stock, from 12,000,000,000 to 60,000,000, with retroactive effect to the close of trading on December 1, 2017,
(iii)	clarify that the reverse stock split effected 1:200 reduction in the number of authorized shares of the Corporation’s preferred stock, from 100,000,000 to 500,000 with retroactive effect to the close of trading on December 1, 2017; and,
(iv)	concurrently therewith, further amend the Corporation’s Amended Certificate of Articles of Incorporation with the State of Delaware to increase the number of the Corporation’s authorized shares of common stock, par value $0.0001 from 60,000,000 to 120,000,000 and reduce the number of authorized shares of the Corporation’s preferred stock, par value $0.001 from 500,000 to 350,000.

Certificate of conversion and designation, description

(i)	The Corporation’s State of Domicile was converted from the State of Delaware to the State of Nevada.
(ii)	The number of authorized shares of capital stock of the Company was increased to:

a. 2,400,000,000 shares of common stock, par value $0.0001 per share

b. 100,000,000 shares of preferred stock, par value $0.001 per share

(iii) The series and number of shares of preferred stock designated from the 100,000,000 shares of preferred stock authorized, was increased to:

a. 1,000,000 shares of Series A Preferred Stock, $0.001 per share

b. 10,000,000 shares of Series B Convertible Preferred Stock, $0.001 per share

Value of settlement agreed to be paid for by issuance of common stock to LAM

$ 69,000

Subsequent Events [Member] | George J. Coates [Member] | Deferred compensation [Member]

Subsequent Event [Line Items]

Additional amount of compensation deferred

$ 34,000

Subsequent Events [Member] | Gregory G. Coates [Member] | Deferred compensation [Member]

Subsequent Event [Line Items]

Additional amount of compensation deferred

10,000

Subsequent Events [Member] | Barry C. Kaye [Member] | Deferred compensation [Member]

Subsequent Event [Line Items]

Additional amount of compensation deferred

22,000

Subsequent Events [Member] | One employee [Member] | Deferred compensation [Member]

Subsequent Event [Line Items]

Additional amount of compensation deferred

$ 4,000

Subsequent Events [Member] | Convertible Promissory Note [Member]

Subsequent Event [Line Items]

Unregistered restricted shares of common stock issued upon conversion

5,068,261

Total amount of convertible notes converted to common stock

$ 29,000

Subsequent Events [Member] | Promissory Note [Member] | George J. Coates [Member]

Subsequent Event [Line Items]

Aggregate cash proceeds

1,000

Subsequent Events [Member] | Promissory Note [Member] | Bernadette Coates [Member]

Subsequent Event [Line Items]

Aggregate cash proceeds

$ 11,000

Promissory note, interest rate

17.00%

Lam Settlement Shares [Member] | Subsequent Events [Member]

Subsequent Event [Line Items]

Percentage of common stock of the company permitted to be held by LAM at any one time

9.99%

Estimated fair value of LAM settlement shares to be received by LAM

$ 99,000

Aggregate amount of past-due obligations settled during the period

$ 40,000

Shares of common stock issued to LAM

8,970,000